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ABSTRACT 
Engineering nanoparticle-protein associations for 
protein crystal nucleation and nanoparticle 
arrangement 
By 
Denise N Benoit 
 
Engineering the nanoparticle - protein association offers a new way to form protein 
crystals as well as new approaches for arrangement of nanoparticles.  Central to this 
control is the nanoparticle surface.  By conjugating polymers on the surface with 
controlled molecular weights many properties of the nanoparticle can be changed 
including its size, stability in buffers and the association of proteins with its surface.  
Large molecular weight poly(ethylene glycol) (PEG) coatings allow for weak 
associations between proteins and nanoparticles.  These interactions can lead to changes 
in how proteins crystallize.  In particular, they decrease the time to nucleation and expand 
the range of conditions over which protein crystals form.  Interestingly, when PEG chain 
lengths are too short then protein association is minimized and these effects are not 
observed.  One important feature of protein crystals nucleated with nanoparticles is that 
the nanoparticles are incorporated into the crystals.  What results are nanoparticles placed 
at well-defined distances in composite protein-nanoparticle crystals.  Crystals on the size 
scale of 10 - 100 micrometers exhibit optical absorbance, fluorescence and super 
paramagnetic behavior derivative from the incorporated nanomaterials. The arrangement 
of nanoparticles into three dimensional arrays also gives rise to new and interesting 
  
physical and chemical properties, such as fluorescence enhancement and varied magnetic 
response. In addition, anisotropic nanomaterials aligned throughout the composite crystal 
have polarization dependent optical properties. 
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Chapter 1 
LITERATURE REVIEW 
 
Central to the work within this thesis is an understanding of how to control protein – 
nanoparticle associations though surface engineering of the particle with a grafted 
polymer.  Preferential nanoparticle – protein associations are then applied to the 
nucleation of crystals and assembly of 3D nanoparticle arrangements.   
1.1. PROTEIN – NANOPARTICLE ASSOCIATIONS 
On a molecular level the biological response to any foreign object is the rapid adsorption 
of multitudes of proteins to the surface, and nanoparticles are no exception to this rule.  
Associations with any of the ~50,000 proteins in the human body will result in the 
formation of a dynamic coating around the particle known as the protein “corona”.3  Each 
protein’s affinity for the nanoparticle surface dictates its presence in the corona which 
varies in quantity and length of time associated.  Figure 1.1, from Lynch’s paper Protein-
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nanoparticle Interactions, Nano Today, is an illustration designed to emphasize  the 
dynamic adsorption and desorption of proteins which work to create a complex protein 
corona that can constantly change.  Essentially, it is the make-up of this corona that 
dictates the biological identity of any nanomaterial, controlling its trafficking, kinetics 
and clearance in the body. Therefore, developing an understanding of how to control the 
proteins that make up the corona has been the goal of researchers using nanoparticles in 
biological environments.  
 
Figure 1.1. Protein corona. 
 
Diagram representing the differences in exchange rates for the protein corona on a 
nanoparticle. The dynamic exchange of proteins on the surface and the surround 
media make the composition of the corona a complex function of the differences in 
exchange rates based on the proteins affinity for the surface. Figure from Lynch, 
Dawson Nano Today 2008, ref [3] 
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1.2. METHODS TO DETECT PROTEIN – NANOPARTICLE 
ASSOCIATIONS 
Analytical approaches to uncover information about the protein corona include: 
determining binding affinities and ratios, detecting conformational changes for the 
proteins, separating and identifying bound proteins, and/or the evaluating binding 
kinetics.
13
  Methodologies for these investigations include: UV-vis, fluorescence 
spectroscopy, dynamic light scattering (DLS), zeta potential (ξ), atomic force microscopy 
(AFM), circular dichroism (CD), fourier transform infrared spectroscopy (FTIR), X-ray 
crystallography (XRD), nuclear magnetic resonance (NMR), size exclusion 
chromatography (SEC), capillary electrophoresis (CE), isothermal titration calorimetry 
(ITC), quartz crystal microbalance (QCM), mass spectroscopy (MS), analytical 
ultracentriguation (AUC) and surface plasmon resonance (SPR).
3,7,13
  It is very difficult 
to find a single technique that would be able to accurately detect all the potential 
information from the protein corona because of the variability of the protein sizes, 
concentrations, binding affinities, as well as the nature and kinetics of their specific 
association.
13
  
Understanding the strengths and weaknesses of each analysis method and employing 
more than one is necessary to form a complete understanding of any nanoparticle – 
bioconjugation.
14
 The Colvin group has by and large measured nanoparticle – protein 
bioconjugation using AUC analysis.
7,15-17
 This sensitive analytical technique is 
particularly useful for detecting associations and quantifying the number of proteins 
bound for an individual protein sample on a nanoparticle.  Figure 1.2 A&B show AUC 
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evaluations to determine association and the binding stoichiometries for proteins on a 
nanoparticle surface.
7
  Changes in the sedimentation coefficient distributions for 
nanoparticle samples with and without proteins are used to detect association, and 
systematically concentration of protein need to saturate the surface.
7
  Through these types 
of evaluation AUC has been shown to be a viable and sensitive analytical method to 
detect strongly bound proteins on a nanoparticle surface.
17
  However, results showing no 
association can be misleading. High centrifugal forces employed could perturb weakly 
bound proteins.
18
 Therefore, it is useful to couple this method with others that are better 
suited for analysis of weak associations.  
 
Figure 1.2. Nanoparticle – protein association, AUC. 
 
 (A) The AUC, sedimentation coefficient distributions for nanoparticle samples 
before incubation (black lines) with a protein solution and after (red lines) are used 
to determine protein association.  Shifts in the peak sedimentation coefficient value 
are used to detect an association; with no association the peaks are unchanged and 
with an association the peaks are shifted to lower s-values. (B) Evaluation of the 
sample with varying concentrations of protein can be used to quantify the number 
of proteins per nanoparticle, figure adapted from ref [7]. 
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Analytical approaches with less perturbation of the sample are necessary for detecting 
weak or dynamic protein associations.
14
  Some successful approaches have been: ITC, 
UV-vis, SEC, and equilibrium dialysis.
3,4
  Figure 3A shows the evaluation of N-
isopropylacrylamide/N-tert-butylacrylamide (NIPAM/BAM) copolymer nanoparticles via 
ITC to detect their interaction with human serum albumin (HSA).
3
  Discernible changes 
were detected using ITC analysis for the copolymer nanoparticles with HSA, however, 
many other proteins known to associate showed no measurable heat changes during their 
analysis.
3,4,14
 The variations in results were attributed to the differences in types of 
binding that occurs, only enthalpic associations can be detected by ITC.  
Another approach, UV-vis spectroscopy can be used to detect both enthalpic and entropic 
associations, but only for binding close to the surface for nanoparticles with consistent 
spectral shifts relative to their local environment.
10,13,19-21
  Figure 3B presents the spectral 
changes for gold nanoparticles from 5 to 80 nm with common human blood proteins.
10
  
However, since the binding has to alter the core nanoparticle to induce a spectroscopic 
shift the thickness of a surface coating or protein layer can be an issue.
14,22,23
   
By far one of the most versatile methodologies presented in literature is size exclusion 
chromatography, SEC. Protein association, strength, and kinetic information can be found 
based on changes in the resonance time for a protein passed through a porous column 
with and without nanoparticles.  Larger materials, such as the nanoparticles, elute quickly 
from the size-exclusion matrix because they are too big to interact with the pores. In 
contrast, smaller materials, such as proteins, are able to enter the pores where the time 
they reside there is dependent on their molecular weight.  Figure 3C displays 
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chromatograms which show that protein associations with the quickly eluting 
nanoparticles decrease the resonance time, so even weak or brief interactions can be 
detected.
3,4
  
Lastly, borrowing a method used to evaluate protein associations with small molecules; 
equilibrium dialysis can be used to measure even weak associations when the size 
difference between nanoparticles and proteins are sufficiently different.
14
  Within this 
thesis, we show that because of the large size difference, protein - nanoparticle 
associations can be determined for small lysozyme proteins with the much larger gold 
nanoparticles, based on their retention in a dialyzed sample.   
 
Figure 1.3. Evaluation of weak protein – nanoparticle associations. 
 
(A) ITC for evaluation of HSA binding to copolymer nanoparticles, figure from ref 
[4]. (B) UV-vis shifts in the peak absorbance position from nanoparticle 
absorbance alone (solid black lines) and with different protein additions (dashed 
lines); figure from ref [10]. (C) SEC elution profiles for nanoparticles and proteins 
without nanoparticles (dashed lines) and with nanoparticles (solid line) for samples 
nanoparticles alone (top), protein with apparent association (middle) and HSA 
(bottom); figure from ref [4] 
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1.3. CONTROLLING NP-PROTEIN ASSOCIATIONS 
Due to the variability inherent in analysis methods, it is difficult to deduce true trends in 
nanoparticle – protein associations; however, in general, particle size, shape and 
hydrophobicity seem to have the most influence on the protein species that adsorb.
24,25
  
Therefore, to gain control of the protein corona requires precise design in size, shape and 
surface coating of the particles. Size and shape of a nanomaterial starts with the synthesis 
of a uniform core particle. Wet chemical approaches have vastly improved this process in 
terms of particle consistency. Most importantly for work on bioconjugation is the surface 
coating material.  A well designed surface strategy will promote or prevent protein 
association.
26
  For biological studies nanoparticles should remain hydrophilic and well 
dispersed in solution; coatings such as: polymers, surfactants, passivating proteins, 
glycoproteins, and polysaccharides are tethered to a nanoparticle’s surface to reduce the 
total adsorption of proteins.
24,27-29
  
By far the most common surface modification material for enhanced control over the 
composition of the protein corona is the polymer; poly(ethylene glycol) (PEG).
30,31
  PEG 
is a flexible, non-ionic, linear chain polymer composed of two carbons and an oxygen 
repeating monomers. It is soluble in a number of solutions and ionic strengths, making it 
highly attractive for use in biological applications.  Furthermore, PEG shows little 
toxicity, is readily cleared from the body, does not elicit an immunogenic response and 
has been approved by the U.S. food and drug administration (FDA) for use in food, 
cosmetics and pharmaceuticals.
32,33
  PEG coatings are not just used for nanoparticles they 
have also been applied to proteins, enzymes, hormones, liposomes, and drug products to 
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improve the pharmacokinetics and pharmacodynamics through increased resonance time 
in the blood stream (half-life).
29,33,34
   
1.4. MECHANISM OF POLY(ETHYLENE GLYCOL) 
The mechanism PEG coatings use to increase circulation times is widely believed to be a 
result of repelling proteins through steric hindrances. For a protein to association with a 
PEG layer there are many thermodynamic barriers it would have to overcome.  Enthalpic 
barriers include the energy required to break hydrogen bonds formed between each 
monomer subunit and up to four water molecules.
24,30-32,35
  Confinement of a protein pose 
possible entropic barriers, which include compression of extended PEG chains and 
causing a loss in the degrees of freedom necessary to allow proteins to associate, 
especially for large molecular weight PEG molecules.
24,30,31
  There would be an entropic 
gain with protein association based on the displacement of water from the associated 
polymer.  Overall, studies of protein association tendencies on PEG covered surfaces are 
inconsistent; ranging from no change in the protein resistances, moderate attractions, to 
complete repulsion.
30
  These inconsistencies could, in large part, be due to the analysis 
methods used, as discussed above for studies involving proteins on nanoparticles.   
In general, increasing the coverage of a PEG layer on a nanoparticle surface decreases the 
amount of proteins that adsorb (figure 4A).
6
  A 2% w/w PEG component in PLA 
copolymer nanoparticles decreased the total plasma protein adsorption by 10% relative to 
the nanoparticle without PEG.  Increasing the PEG concentration to 5% w/w, for the 
same PLA nanoparticles, suppressed 70% of the total plasma protein adsorption, showing 
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that even small changes in the surface composition of the PEG layer decrease the surface 
affinity of proteins.
24,36
 With a complete layer formed from a high polymer surface 
coverage, theoretically the plasma protein adsorption could effectively be 
suppressed.
3,24,37
 
 
Figure 1.4. PEG coverage deceases protein association. 
 
Adequate PEG coverage needed for protein repulsion is dependent on the polymer 
grafting density and molecular weight for a given nanoparticle radius of curvature.
38
 
Figure 5 shows that PEG molecules tethered to any surface are able to assume either a 
mushroom or brush conformation, based on the amount of extension.  When the distance 
between polymers is sufficiently greater than the Flory radius (Rf) of the polymer, there 
are more intramolecular associations and the molecule takes on a “mushroom” 
(A) Increased PEG concentration decreased the amount of protein that adsorbed 
and the sites available for protein adsorption, figure from ref [6]. (B) Illustration of 
increased PEG coating with resulting serum protein association and macrophage 
uptake, figure from ref [9]. 
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conformation.
32
  However, increasing the number of polymers in a given surface area 
eventually leads to decreased distances between molecules and more intermolecular 
associations. When the extension of the polymer is greater than the distance between 
molecules the conformation is a “brush”.39,40  For nanoparticles the PEG packing and 
conformation is influenced by the radius of curvature. The distance between polymer 
molecules necessary to call the conformation a brush, for a flat surface is d < Rf, while on 
a curved surface any d < 2Rf is in a brush conformation.
2,11,32
  Once a PEG layer has 
obtained a brush conformation the surface tends to be inert, showing little to no attractive 
forces, or protein association.
36,41
  Therefore, controlling the conformation of the PEG 
layer is a specific strategy that can be used to design surfaces for preventing or promoting 
protein associations.   
 
Figure 1.5. PEG conformation on a surface. 
 
(A) Conformation of PEG on a flat surface is a brush when the distance between 
polymers is less than the Flory radius (Rf), figure from ref [2] For curved surfaces 
the conformation changes from mushroom to brush when the distance between 
polymers is less than twice the Flory radius (Rf) of PEG on a curved surface from 
ref [ 11]. 
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1.5. ADVANTAGEOUS PROTEIN – NANOPARTICLE 
ASSOCIATIONS 
Protein – nanoparticle interactions can be advantageous for applications such as targeting, 
enhancing enzyme activity, nucleating protein crystals and forming nanoparticle 
assemblies.
42-44
  Thus far, we have discussed research aimed at understanding protein 
associations in order to eliminate them; however promoting controlled associations with 
advantageous proteins is used for biomolecular delivery of nanoparticles to site specific 
areas of the body.
43
  Targeting proteins such as albumin, antibody, transferrin, cytokine 
and low-density lipoprotein can be tethered to the nanoparticle surface are used as active 
targets.
26
  However, promoting strong associations between highly curved nanoparticle 
surfaces and protein molecules will often affect the protein’s secondary structure and its 
function.
24,45
  
Protein – nanoparticle associations impact the nanoparticle by directing its biological 
behavior and the nanoparticle in turn impacts the function and fate of the protein through 
conformational changes.
26
 Adsorptions of proteins on nanoparticles have been shown to 
cause the protein to either denature or obtain a more stable structure. Ultimately, loss of 
conformation can result in the destruction of protein’s function and formation of fibrils. 
Conversely, more stable structures can show enhanced activity and formation of 
crystals.
12,24,26,42,44-50
   
The nanoparticle diameter, shape and surface hardness influence the resulting structural 
changes for a bound protein.  Figure 1.6 shows that the protein associated with the small 
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nanoparticle was more likely to retain its native structure, while the large nanoparticle 
causes the protein to denature.
5,26
  Since denaturation is the first step in the formation of 
protein fibers, it isn’t surprising that nanoparticles have been found to induce fibrillation 
for β2m proteins.12 Accumulation on the nanoparticle surface creates a closer proximity 
between the now denatured proteins which in turn promote rapid between exposed 
hydrophobic residues.  These protein–protein interactions result in the formation of long 
fibers, seen in figure 1.6C. However, when the secondary structure of the protein is 
retained, the close proximity and locally high concentration can promote protein-protein 
associations that can induce protein crystal formation. Polystyrene and gold nanoparticles 
have been shown to have properties that nucleate protein crystallization, perhaps due to 
retention of the native protein structure upon binding.
49,50
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Figure 1.6. Nanoparticle – protein association affect protein 
conformation. 
 
Controlled associations between nanomaterials and biomolecules, such as proteins, 
nucleic acids, and other macromolecules have been used to create inorganic and organic 
nanostructured and mesoscopic hybrid architectures for possible uses in biological 
research, electronics and sensing applications.
44,51
 Most commonly, organizations of 
nanomaterial into adaptable two dimensional arrangements with long range control have 
been formed on films made from molecular arrays of crystalline bacterial surface layer 
(S-layer) proteins.
52,53
 Studies of the properties nanomaterials exhibit in complex two 
dimensional arrangements have revealed many interesting cooperative effects for 
metallic, semiconductor and magnetic nanoparticles, however more complex three 
dimensional assemblies could have even more profound ensemble interactions.
44,52,54
  
(A) Protein structure on a curved nanoparticle surface can be protected against loss 
of secondary structure, even in harsh environments or they may  denature, figure 
from ref [5]. (B) Kinetics of β2m fibrillation in the presence of nanoparticles, show 
nanoparticle nucleate the formation of fibrils. (C) Negative stained TEM image of 
the fiber formed with 70 nm nanoparticles, figure from ref [12]. 
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One approach to generating complex nanostructure mesoscopic assemblies utilizing the 
natural ability of DNA to self-assemble, based on the union of base pairs.  DNA subunits 
are functionalized to create oligonucleotide modified nanoparticles which are driven to 
assemble into complex two dimensional and three dimensional structures.
1,44,55
  Figure 
1.7 shows a three dimensional arrangement of nanospheres coordinated through DNA 
segments as an example of the types of materials that have been produced by Chad 
Mirkin’s research group at North Western University.1,55  DNA crystallizes nanomaterial 
into structures with exquisite control, showing the capabilities that can be possible when 
using biological templating.
56,57
  However, the functionalized oligonucleotides required 
for tailoring the design of these three dimensional assemblies are not produced in nature; 
and they require time and expense to create.   
Strategies that use naturally occurring biomolecules for directed assembly would 
decrease the cost and increase the feasibility of creating large amounts of the 
nanostructured architectures.
55
  Native proteins can be driven to self-assemble into three 
dimensional structures by providing an environment weak associations are favored.  
Protein crystals structures are large, porous and regularly spaced and in can be perturbed 
to crystallize into different shapes and symmetries.  three different roles; hollow proteins 
with internalized nanomaterial, porous protein crystals structures as scaffolds infused 
with metals and composite crystals through directed nanoparticle – protein associated 
conjugates.
8,58,59
  Understanding and controlling the surface properties of nanoparticles 
will lead to applications beyond the biological realm. The potential for material science 
engineering through nanoparticle biomolecule manipulation is exciting. 
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Figure 1.7. Three dimensional assemblies of nanoparticles. 
 
  
(A) Nanoparticle assemblies from controlled association with (A) DNA, figure 
from ref [1] and (B) lysozyme , figure from ref [8]. 
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Chapter 2 
MATERIALS AND METHODS 
This Chapter describes the synthesis and characterization methods used throughout this 
thesis.  First, the detailed procedures for producing nanoscale spheres, rods and 
bipyramids of gold are presented; additionally, nanoscale iron oxide and cadmium 
selenide materials were produced.  Characterization of these materials relied on a variety 
of tools including microscopies, vibrational spectroscopies, elemental analysis and x-ray 
diffraction.  Finally, approaches to the analysis of the biological-nanoparticle interface 
are presented along with the methods employed for protein crystallization. 
2.1. NANOPARTICLE SYNTHESIS / PEGYLATION /  
SAMPLE PREPARATION 
2.1.1. Gold nanoparticles 
Gold nanoparticles of 5, 10, 15 and 20 nm diameter were purchased from Ted Pella 
(0.01% gold chloride, <10% coefficient of variation for mean diameter).  Additionally, 
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~10 to 15 nm diameter gold nanoparticles were also synthesized in the lab using Frens’ 
method.
1
 Briefly, a 1 mM HAuCl4·3H2O (Sigma Aldrich, 99.9+%) solution was heated 
until boiling.  Then, a preheated 10% w/w sodium citrate (Fluka, >99.0% pure) solution 
was added (1mL for every 10 mL gold solution).  Following the addition of the citrate the 
reaction mixture was allowed to boil for 15 minutes. During this time, the citrate reduces 
the gold ions in solution which leads to the formation of gold nanoparticles; Figure 2.1A 
outlines this process.  As the particles nucleated and formed, the solution progressed 
through a range of colors from yellow to colorless then gray, purple and finally dark red, 
shown in the series of images in Figure 2.1B.  After the 15 minutes of heating, the 
solution was cooled rapidly by running water over the outside of the flask. Highly 
crystalline, gold nanoparticles between 10 – 15nm are the result (Figure 2.1C). The 
particle size can be tuned by varying the ratio of gold ions to citrate molecules. 
2,3
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Figure 1.8. Gold nanoparticle synthesis. 
  
2.1.2. PEGylation of gold nanoparticles 
Thiol functionalized poly(ethylene)glycol (Creative BioChem, 95 ± 3%) of either 1K, 
2K, 5K, 10K, 20K or 30K molecular weight was used to functionalize the gold 
(A) Gold nanoparticles are synthesized from a solution of Au+3 ions.  (B) As 
particles form and develop the solution progresses through a series of colors 
depending on the size of the nanoparticles in solution. (C) TEM images show the 
typical sizes of the nanoparticle produced for this synthesis are between 10 – 15 
nm, and are highly crystalline.
2,3
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nanoparticles.  Excess PEG-thiol (~3000 PEG/particle) was added to the gold 
nanoparticles in solution, and the resulting solution was stirred for at least 12 hours, to 
allow time for the polymer layer to form. After this treatment, it was necessary to purify 
the samples to remove unreacted PEG-thiol.  Sample purification required both three spin 
filtration treatments, followed by an additional three rounds of centrifugation.  First, the 
solution was exposed to a maximum filter cutoff of 100 molecular weight, which retained 
all of the nanoparticles but allowed the unbound PEG-thiol to pass through. Samples 
placed in the spin filter vials (Millipore) were centrifuged three times at 4150 RPM for 15 
minutes (or until most of the solution was removed from the sample). The remaining 
~150 μL pelleted sample was resuspended in Milli pore ultrapure water.  Additionally, 
samples were further cleaned three times via sedimentation either on the benchtop Sorel 
Centrifuge (particle diameters  > 10nm) or the Beckman Ultracentrifuge.  The typical 
RPM employed (30,000 RPM (5 nm), 20,000 RPM (10 nm), 11,000 RPM (15, 20nm)) 
sedimented the nanoparticles into a pellet, and left a colorless supernatant containing any 
excess PEG-thiol and less dense impurities.  The nanoparticles were then resuspended in 
Milli pore ultrapure water and the procedure was repeated. Following purification of the 
sample, the solution concentration was adjusted so as to ensure a constant optical density 
at the (λ = ~520 nm) peak absorbance position.  Absorbance peaks for 10 nm gold 
nanoparticles were diluted to obtained an optical density of 1.0 ± 0.2 absorbance units 
(~9.5 nM), at 520 nm unless otherwise stated.
4
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2.1.3. Synthesis, PEGylation and purification of shaped gold 
nanoparticles (rods and bipyramids) 
*All gold nanorod and bypriamid synthesises, PEGylations and purifications were carried 
out by Courtney Payne, in the Hafner Lab. I provided the PEG and helped amend the 
PEGylation and purification procedures. 
Gold nanorods were synthesized in a seed-mediated synthesis as described by Sau and 
Murphy.
5
  Gold bipyramids were synthesized as previously reported in a two-step 
synthesis; formation of a seed solution and a bipyramid growth solution.
6
 PEGylation of 
gold nanorods and gold bipyramids was performed using the 20,000 MWt PEG-thiol. The 
PEGylation procedure was followed as reported previously.
7
  
2.1.4. Quantum dots  
*All quantum dot and iron oxide nanoparticle syntheses, PEGylations and purifications 
were carried out by Huiguang Zhu in the Colvin Lab. 
The CdSe, which form the quantum dot cores, was formed in a now common synthetic 
procedure under ultra-pure N2 flow.
8
 The method for CdSe/CdZnS QDs synthesis was 
adapted from our previous work.
8
 The reaction was run under ultra-pure N2 flow. The 
purified CdSe core quantum dot solution suspended in chloroform was transferred into a 
three-neck flask and the solvent was pumped off by vacuum. ODA (Aldrich, 
Octadecylamine, 97%) and ODE are then added into the flask and heated to 150C. 0.04 
M zinc (Aldrich, Zn(OAc)2, 99.99%) solution was formed in 0.5 g TOPO, 2.0 mL TOP, 
and 8.0 mL of ODE heated to 200 °C. Similarly a 0.04 M cadmium solution was 
prepared.  Zinc/cadmium were add in a molar ratio of 1:4, to form precursors and 
thiourea/ethanol solutions were injected into the flask via syringe, alternatively, and the 
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mixture was stirred for another 60min. The reaction was cooled to ~60C and then the 
particles were precipitated using acetone and rinsed with ethanol. The core/shell quantum 
dot pellets can be redispersed into a variety of solvents including hexane, chloroform, and 
toluene.  
Iron oxide nanocrystals were synthesized based on the method reported previously.
9
 The 
nanocrystals were purified using methanol, acetone and hexane. First, 5ml of the as-
prepared nanoparticles were washed using 25 mL of methanol and 25 mL of acetone to 
remove unreacted iron carboxylate, surfactant, and 1-octadecene. The purification 
process was repeated 3 times. The cleaned nanoparticles were then re-dispersed in 15 ml 
of hexane and separated from unreacted salt and other impurities by centrifugation at 
4500 rpm for 30 min. The purified black iron oxide nanocrystals were easily dispersed in 
chloroform, THF, toluene or any other nonpolar solvent. 
An amphiphilic copolymer poly(maleic anhydride-alt-1-octadecene) (PMAO) (Mn = 30K 
-50K)-PEG (Mn = 1K, 2K, 5K, 10K, 20K) (molar ratio PMAO:PEG=1:10) was formed 
on the surface of iron oxide and quantum dot particles through an anhydride coupling 
reaction by mixing PMAO and PEG in chloroform overnight.
10
  This polymer was mixed 
with purified nanoparticles in chloroform, vacuum dried and re-dispersed in ethyl ether. 
A pH 10 borate buffer was added and the mixture was probe sonicated for 30s. The ether 
was evaporated off and a clear solution was formed.  The polymer-capped nanoparticles 
were then centrifuged at 35,000 RPM for 4 hours, three times, to remove any excess 
polymer. The purified water-solubilized NPs were stored in 50 mM borate buffer (pH 10) 
in the dark.
11
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2.2. NANOPARTICLE CHARACTERIZATION 
2.2.1. Transmission electron microscopy (TEM):  
2.2.1.1. Sample preparation:  
Preparing nanoparticles for successful TEM imaging requires control of sample 
concentration, drying time and the appropriate grid material. Samples need to contain 
enough particles to give some color to the solution, but not so many that it is deeply 
colored. With such solutions, 10 to 20 L of sample are placed onto a copper grid, using 
a micropipette, and allowed to evaporate slowly. Drying time can be controlled by 
placing the grid on an appropriate substrate such as a piece of glass (slow) or a kimwipe 
(fast). For aqueous samples the grid should be placed on a hydrophobic surface so the 
sample will not spread and the droplet can dry uniformly over a long period of time.  
Conversely, organic solvents should be wicked away quickly so the grids would be 
placed on filter paper or another absorbent material.   
TEM sample support grids are chosen based on the approximate size of the 
nanomaterials, the magnification anticipated for imaging and the applications (i.e. Gatan 
image filtering (GIF), electron diffraction, analytical scanning imaging device (ASID), 
scanning transmission electron microscopy (STEM)) you will be running.   
Size, size distribution and shape information for nanoparticle sample are commonly 
determined from TEM images. Some key things to remember while taking images that 
will be processed on the sizing software are: higher contrast is better than higher 
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magnification; large clumps of materials are not suitable as edges of nanoparticles cannot 
be detected; and any particles on the edges of the image will not be counted so try to get 
as many particles in the middle of an image as possible.  Large particles should be 
imaged at the lowest magnification where individual particles can still be resolved (10K - 
80KX). Because magnification affects both the contrast and resolution, inversely to each 
other, a high magnification increases the resolution while decreasing the contrast.  It is 
much easier for sizing software to detect the edges of particles when they are at a 
maximum contrast; therefore, the ideal magnifications for sizing are between 10K and 
80K, for gold nanoparticles between 5 and 20 nm 20K magnifications are best, Figure 
2.2A shows a typical microgram of 10 nm gold nanoparticles at 20K that would be 
suitable for size analysis. For these magnifications the grids can have large mesh and 
thicker formvar coating, such as a 300 mesh copper grid with a formvar type A or B 
support.   
One problem with the 300 mesh grids is that they have large openings between copper 
mesh which will contribute to sample drift and vibration at higher magnifications.  
Therefore, when imaging at higher magnification a higher count mesh (400 mesh) should 
be used. Sizing for small particles (<5nm) can be affect by the thickness of the grid 
coating, especially those made of low contrast materials like iron oxide or semiconductor 
materials.  For these samples a holey carbon support on 400 mesh grid, should be used.  
The holey carbon support provides areas where there is no substrate, just particles, which 
makes it easier to obtain high contrast images at higher magnifications. However, 
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because the support materials are thick and have an unusual shape they interfere with the 
image and should not be used at low magnifications (<30KX).   
The ideal grid for working at low or high magnification and when attempting ASID, GIF, 
or energy dispersive spectroscopy (EDS) methods is the ultrathin carbon type A, 400 
mesh copper grids. For these grids the mesh is small which minimizes drift and vibration 
and the carbon support is uniform and thin which allows for the best resolution – a vital 
optimization for these applications. 
2.2.1.2. Instruments: 
 At Rice there are currently four shared equipment authority (SEA) TEMs:  
 a JEOL 1230 high contrast TEM (HC-TEM) run at 120 kV,  
 two JEM 2010 TEMs run at 100kV (CryoTEM, TEM) 
 a JEM 2100F with a field-emission gun and operated at 200kV (JEM2100F 
TEM).   
The HC TEM is the first TEM that most users are trained on and it is fine for normal 
imaging operations. It does low magnification, high contrast imaging so it is the best 
option for large particles or any sample that has been thinly sliced, like biological 
samples in resin. The HC-TEM has some advanced capabilities such as a double tilt 
sample holder which is used to run tomography. The CryoTEM can be used to image 
vitreous ice samples. For routine use the two JEM2010 instruments are identical. They 
both have 5 position holders allowing for imaging of multiple samples without having to 
pump down the sample chamber (which is time consuming) and they work well at the 
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magnification range suitable for sizing and characterizing nanoparticles.  The JEM 2100F 
TEM has a lot of additional capabilities.  The field emission gun is a more coherent 
source of electrons, which allows this instrument to be run at up to 1.5 million 
magnification.  This is necessary in order to image the lattice spacing of crystalline 
samples (Figure 2.2C).  Furthermore, it can be used in scanning mode (analytical 
scanning imaging device, ASID) which allows the TEM to be used as a scanning 
transmission electron microscope (STEM). Figure 2.2 E is an ASID image of iron oxide 
nanoparticles with uranium adsorbed to their surface. The ASID is also equipped with a 
detector which identifies the energy of X-rays backscattered from the sample for 
composition based analysis called energy dispersive spectroscopy (EDS). With such 
information, it is possible to determine the elemental composition of the materials and 
even map there locations on a sample. Figure 2.2D is an EDS spectrum for sample shown 
in Figure 2.2E, where peaks can be seen for iron, uranium and copper (contribution from 
the grid).  Additionally, there is a gatan image filtering (GIF) camera that is capable of 
taking electron energy loss spectrums (EELS) which, like energy dispersive spectroscopy 
(EDS), determines the composition of the sample, and it can filter an image to show the 
distribution of the different elements in the viewing area, see Figure 2.2D for GIF image 
and 2.2F for EELS spectrum.  
2.2.1.3. Image processing:  
Processing the images on Imagepro software is done to determine the shape, size and size 
distribution information for the inorganic core nanoparticle. Embedded software 
programs, termed macros, have been set up in this software to aid in this process. For 
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reporting the dimensional data, is it important to count many particles.  Typically at least 
1000 particles are needed to obtain both the diameter and the standard deviation of the 
diameter for nanoparticle samples; if samples are odd-shapes even more particles will 
need to be analyzed. 
 
Figure 1.9. TEM Analysis. 
 
TEM micrographs of gold nanoparticles (A) at sizing magnification (40KX) with 
(B) electron diffraction pattern, and (C) at high magnification (800KX) where 
lattice planes can be visualized.  (D) GIF image filter of zinc and TiO2 
nanoparticles extracted from sunscreen. (E) EDS map on an ASID image of 
uranium adsorbed to iron oxide nanoparticles. (F) EELS spectrum from gold 
nanoparticles. (G) EDS spectrum from the sample in (E). 
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2.2.2. Dynamic light scattering (DLS):  
A Malvern Zen6300 Zetasizer NanoS equipped with a 633 nm laser was used to 
determine the hydrodynamic diameter of particles.  The Brownian motion of materials in 
solution creates a specific autocorrelation in light scattering data; this autocorrelation 
function is what is used to back out the diameter of nanoparticles. It is a method best 
suited for samples with diameters between 20 and 1000 nm that are non-aggregated in 
solution.  Using DLS, the sample can be evaluated within its native solution and the 
measured diameter includes both the dimensions of core material as well as any 
associated surface ligands.  Typical data collections are taken three times, and the user 
must input the refractive index and absorbance (at 633nm) for the materials.  For gold 
nanoparticles these values are 1.35 and 0.1, respectively.  The zetasizer software will 
automatically optimize the measurement for the number and length of each scan. The 
number of scans the software chooses can be a good indication of the quality of the 
sample, typical runs requires 10 – 18 scans and inappropriate samples – those with a very 
high or low level of scattering - require much more.  
The major factors which dictate the success or failure of a DLS measurement are: sample 
contaminants, sample concentration, ionic strength, and induced motion.  Contaminants 
such as dust, aggregates, or unremoved coating materials affect DLS measurements; 
these can be addressed through a simple purification including a syringe filtration right 
before measurement. The material concentration should not, in principle, affect the 
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reported measurement, but when samples are too concentrated or too dilute then it is not 
practical to get quality scattering data.  As it is hard to know a priori what the best 
concentration might be for a sample.  The best approach to determine an optimum 
concentration is to run the sample at several concentrations and monitor the reported size 
and polydispersity index and count rate; once the samples are within an appropriate 
concentration range the size and polydispersity index should no longer change, but the 
count rate will (at concentrations too high or too low the count rate may not change with 
concentration because the detector is saturated or the signal is too weak to detect). 
The last issue for DLS is the minimization of any induced movement in the sample itself.  
Thermal variations, particle sedimentation, or mixing will all introduce substantial errors 
into the scattering analysis and the results will not be usable. It is vital to first equilibrate 
the sample to the temperature of the instrument; additionally, do not overfill curvettes 
higher than 10 mm (1mL in the 1 cm X 1cm cuvette).  Finally, if samples are dissolving, 
aggregating or sedimenting then the data will not be reproducible.  The count rate signal 
is the best indication that a sample is changing, if the signal is anything besides a semi-
straight line that looks like noise there is fluctuation within the sample.  
There are three outputs from the DLS which can be used to extract the hydrodynamic 
diameter: signal intensity, volume corrected and number corrected scattering 
autocorrelation curves.  Intensity measurements are directly calculated from the Stokes-
Einstein equation and are not influenced by the corrections for viscosity, refractive index 
or absorbance.  So this data is less sensitive to user parameters that may be estimated for 
nanoparticles (e.g. refractive index).  However, larger materials scatter light far more 
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effectively than smaller materials and so a reliance on intensity data can skew the size 
distributions.  The DLS software also provides volume and number correction factors that 
attempt to correct for this effect.  Number corrected data tends to overestimate the 
population of the smallest materials and usually shows no report of other size populations 
present in the sample.  Volume corrected data generally provide an accurate 
representation of all the size species present in a sample.  The diameter data throughout 
this thesis was thus derived from the most abundant peak in the volume corrected data; 
this data was found to be the best match to predicted hydrodynamic diameters derived 
from the TEM of nanoparticle cores and estimates of the molecular dimensions of surface 
coating materials.  
Figure 2.3 shows two typical applications for DLS data: determining core particle 
diameter (d), as compared to the values determined from TEM and determining 
hydrodynamic diameter (HD) which is d plus the organic coating.  
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Figure 1.10. DLS Analysis. 
 
2.2.3. UV/Vis absorbance:  
A Varian (Agilent) Cary 5000 UV/Vis Spectrometer was used to obtain optical 
absorbance data.  Cuvettes are used to hold liquid samples; the volume and material of 
cuvettes are dependent on the analysis being performed.  Within this thesis the optical 
absorbance data was obtained from 250 nm – 800 nm (unless otherwise stated) and 
samples are run in either 0.5 mL small volume quartz cuvettes (protein stock solutions) or 
poly methyl methacrylate (PMMA, optically clear  to 300 nm) disposable 4.5 or 2.5 mL 
Core nanoparticle diameters and distribution (A) for 5, 10, 15 and 20 nm gold 
nanoparticles show similar values from TEM and DLS. The black dashed line is 
1:1 as a guide to the eye. (B) DLS data for the evaluation based on the change in 
the hydrodynamic diameter (HD) for increased PEG molecular weights coated on 
for four core diameter gold nanoparticle samples.  
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cuvettes.  All samples are run with a baseline correction scan on an identical cuvette 
filled with solvent (a blank) initially on both beams and then with a blank sample in the 
rear beam position during analysis. Absorbance characteristics relevant for the gold and 
quantum dots materials used in this work include the identification of peaks whose 
height, position, and width can be used to infer information about nanoparticle samples 
based on size (Figure 2.4A), concentration (Figure 2.4B), shape, and/or purity. The 
extinction coefficient (ϵ, M-1 cm-1) used to determine the concentration of gold 
nanoparticles changes based on the size of the particles.  It can be calculated for any 
spherical gold nanoparticle sample using Equation 2.1 based on the natural log (ln) of the 
core particle diameter (d, nm) determined using TEM analysis.
4
 
 
Equation 1.1. Extinction coefficient gold nanoparticles 
  ( )          (  ( ))           
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Figure 1.11. UV-Vis Analysis. 
 
2.2.4. Analytical ultracentrifugation (AUC):  
A Beckman XL-A Analytical Ultracentrifuge equipped with a UV/Vis detector and an 
An60 four position rotor was used to run velocity sedimentation analyses on 420 L 
liquid samples housed in 12mm, dual window, epon centerpieces.  Centrifuge speeds and 
scan rates are chosen so the sample absorbance boundaries remain vertical and migrate 
uniformly for at least 40 scans. Sedimentation coefficient distributions for each sample 
were obtained using SEDFIT ls(g*) analysis, which is design to monitor large, discreetly 
sedimenting particles without interactions or back diffusion.  The peak s-values are a 
direct measurement of particle size and density and therefore are useful for evaluation of 
particle size, surface functionalization or bioconjugation.
12-15
 
Absorbance information can be used to evaluate gold nanoparticles for a number of 
characteristics, such as: (A) size and (B) concentration. 
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Figure 1.12. AUC Analysis. 
 
2.2.5. Total organic carbon analysis (TOC):  
Organic carbon concentrations were determined using Shimadzu TOC-L run on either a 
non-purgeable organic carbon concentration analysis (NPOC) or total organic, inorganic 
and nitrogen (TOC/TN) concentrations analysis.  The non-purgeable organic carbons in 
solution were used to quantify carbon containing polymers and Figure 2.6 shows this 
information can be used to evaluate the efficacy of a cleaning procedure or determine 
surface functionalization on nanoparticles. Alternatively, the nitrogen concentration can 
be used to quantify proteins in solution making it useful to evaluate bioconjugation or 
protein crystallization yields. 
Analytical ultracentrifugation used to determine the sedimentation coefficient 
distribution of nanoparticles based on their size and density.  (A) Nanoparticles 
from 5 to 20 nm are evaluated and (B) plot of s-value vs. diameter is a cubed fit.  
(C) Increasing the molecular weight of the polymer coating materials decrease the 
particle density and (B) decreases the sedimentation coefficients. 
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Figure 1.13. TOC Analysis. 
 
2.2.6. Thermogravimetric analysis (TGA):  
TA Instrument’s Q-600 Simultaneous TGA/DSC is run on approximately 1 mg of gold or 
PEGylated gold nanoparticle samples (~9.0 nM) which requires 10 mL of sample to be 
concentrated to <100 μL, which is then dried on the TGA to obtain a powder. Each 
concentrated sample was first dried at 100 
°
C for 60 min to remove excess water and then 
baked at 140 
°
C for 60 min to remove the bound water. Analyses were performed under a 
100 mL/min flow of air and using a stepwise isotherm method where the temperature was 
ramped from 150 
°
C to 1200 
°
C. Briefly, the stepwise isotherm method was designed to 
hold at temperatures where the rate of weight loss was greater than 1 wt% per min. 
However, when the rate of weight loss decreased below 1 wt% per min the temperature 
returned to a steady ramp of 5 °C per min. The mass of sample loss from 150
 °
C to 500 
°
C 
is attributed to the organic component.
16
   
Total organic carbon analysis is used to determine carbon and nitrogen 
concentration of solutions.  This information can be used to (A) evaluate cleaning 
procedures, (B) monitor surface functionalization, or (C) detect protein 
concentration. 
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Figure 2.7A shows that a pure PEG powder loses most of its mass (>99%)between 150 
°
C 
and 500 
°
C with a maximum derivative peak at 229
 °
C (FWHM, 65 
°
C).
16
  Thus, when 
similar mass changes are seen for polymer-coated nanoparticles it is possible to identify 
and ultimately quantify the amount of coating material.  For example, Figure 2.7B shows 
the TGA data collected for for 10 nm gold coated with increasing molecular weight of 
PEG. 
 
Figure 1.14. TGA Analysis. 
 
2.2.7. Flocculation assay:  
Flocculation assays are used to determine the minimum concentration of a precipitant that 
induces aggregation of nanoparticles. A colorimetric method was developed to detect the 
flocculation of gold nanoparticles to determine the stabilization effect of the polymer 
coverage, it was adapted from several similar methods.
17,18
  Briefly, the optical 
TGA is used to determine the carbonaceous content of a solid sample through 
changes in weight during thermal ramping.  This information can be used to 
evaluate (A) purity of organic materials, or (B) determine organic contribution from 
polymer surface functionalization on inorganic nanoparticles, (C) percent organic 
trends with PEG molecular weight. 
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absorbance of samples housed in 96-well plates were collected using a SpectroMax brand 
UV/Vis multiwell plate reader at =520 nm for unaggregated particles and =595 nm for 
aggregated, Figure 2.8A.  The precipitant concentration was varied systematically from 0 
to 2.5 M (for salts) and the ratio of the aggregated to unaggregated absorbance peaks 
were used to determine the aggregation factor, which was a measure of the extent of 
aggregation. Figure 2.8B shows the results of a flocculation assay used to evaluate the 
effective polymer coatings on gold nanoparticles.  The citrate stabilized gold 
nanoparticles have an aggregation factor >1 in relatively low ionic strength solutions, 
whereas, the addition of polymer coating materials adds stability to the nanoparticle 
sample and increased the amount of salt needed to induce aggregation. The minimum 
concentration of precipitant needed to induce aggregation is called the critical 
coagulation concentration (CCC), it is taken to be the concentration of salt where the 
aggregation factor raises by 15%. The CCC increased with more organic coating material 
(PEG) in solution, which show that polymers provide stability to the particles against the 
charged ions in the salt solution. 
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Figure 1.15. Flocculation Analysis. 
 
2.2.8. Equilibrium dialysis:  
Float-A-Lyzer
®
 G2 1 mL screw top 100 MWCO dialysis cellulose ester membranes 
(Spectra/Por
®) were filled with 100 μg/mL lysozyme solution and 4 nM polymer – 
nanoparticle conjugate material.  Membranes were placed in 450 mL of 0.1 M sodium 
acetate (Fluka, 99.7%) buffer pH 4.6 and allowed to dialyze for 6 days. Protein and 
polymer – nanoparticle conjugate concentrations were determined for the sample 
(A) Flocculation assays use the shift in the plasmon resonances for gold 
nanoparticles due to aggregation to detect stability.  The peak absorbance at 595 nm 
divided by the absorbance at 520 nm is used to calculate the aggregation factor, 
which is a clear indication if a sample is aggregated. (B) Flocculation data for a 
gold nanoparticle sample with increasing 2K PEG concentration what that with 
increased PEG concentration the sample becomes more resistant against 
aggregation in high salt concentration solutions. 
 58 
 
spectroscopically before dialysis and after to determine percent protein retained in the 
sample. 
2.3. PROTEIN CRYSTAL PREPARATION  
All protein crystallization experiments were run by me, however training and support and 
set up of the high throughput crystallization robot were provided by Kasia Walkiewicz 
from Dr. Shamoo’s Lab.  
2.3.1. Crystallization Buffers:  
The crystallization procedure for lysozyme has been developed through evaluation of a 
range of protein concentrations, pHs, ionic strengths and additives; similar to conditions 
used by Falkner et al.
19
 The standard procedure reported here has been chosen because it 
consistently yields crystals and not protein aggregates.  Crystallization reagents consist of 
a solution of 0.1 M sodium acetate buffer at pH 4.6 and 1 M NaCl (Fisher, 99.7%, 
crystalline biological, certified) (unless otherwise stated).  The buffer was prepared by 
dissolving 8.2 mg sodium acetate (Fisher, Certified ACS, 99.7%) per mL of water and 
adjusting the pH using 12.1 M HCl (EMD chemical, ACS grade).  All solutions were 
vacuum filtered through a 0.2 m filter to remove any possible contaminants then stored 
in tightly sealed glass media bottles for storage. Solutions were considered stable and 
usable while they remain optically clear and their pH is within ± 0.1 of the initial 
preparation.  
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2.3.2. Protein Stock Solutions:  
Lysozyme (Aldrich, >98%) stock solutions were prepared in 0.1 M pH 4.6 acetate buffer, 
where ~50 mg protein/mL was added, and the solution was mixed until transparent, then 
gently centrifuged at 3.3K RPM for 10 minutes to remove any impurities or undissolved 
protein. The actual protein concentration was determined photometrically using the 
optical absorbance at 280 nm of a 100X diluted solution. The final concentration was 
calculated using Beer’s Law with an extinction coefficient of 2.64 mL mg-1 cm-1.19,20 
Protein stock solutions: Pure protein samples of ferritin (pure), human serum albumin 
(HSA) (>97%), (Sigma Aldrich) lipase B, xylanase, and glucose isomerase 
(Crystallization standards, pure, Hampton Research). Stocks were suspended in filtered 
solutions, and centrifuged gently at 3.3K RPM for ten minutes to remove any undissolved 
materials. Protein concentration was determined spectroscopically at 280 nm using 
extinction coefficients provided by the manufacturer where available or a generic 1 
mg/mL per absorbance unit, when no extinction coefficient could be found.  As 
purchased ferritin stock solutions are 50 mg/mL and were diluted to 30 mg/mL using 
MilliQ DI.  Dried lyophilized powders of HSA were measured out to be 10 mg/mL into 
0.01 M phosphate buffer pH 7.0. Lipase B stock solution was prepared by weighing out 
enough materials to produce a 35 mg/mL solution in MilliQ DI.  The stock solution for 
xylanase started at 30 mg/mL and was diluted to a final concentration of 18 mg/mL using 
MilliQ DI. Glucose isomerase suspended microcrystals were dialyzed in 10 mM HEPES 
(Aldrich, >99.5%)buffer pH 7.0 with 1mM MgCl2 (Aldrich, Certified ACS) overnight, 
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and then diluted to a final concentration of 10 mg/mL using the same solution of HEPES 
and MgCl. 
2.3.3. Protein Crystallization Methods 
2.3.3.1. Hanging drop method:  
Hanging drop crystals were formed via a vapor diffusion method as shown in Figure 
2.9A. Small volumes of crystal reagent solution and protein were suspended from 
silicone coated glass cover slips covering each reservoir in pre-greased 24-well plates 
(Hampton Research).  Reservoir solutions are prepared with the crystallization reagent.  
Within each sample droplet there is 1 L of reservoir solution, 2 L of the lysozyme 
stock solution and 1 L of nanoparticle additive solution or DI.  The cover slip was then 
inverted over the well and pressed into the vacuum grease to create a seal.  The well 
plates were placed in a temperature controlled environment (10 ºC ± 1ºC) and allowed to 
crystallize.  
2.3.3.2. Sitting drop method:  
A vapor diffusion crystallization method was also used to form crystals in small volume 
solutions for a sitting drop crystallization method. As shown in Figure 2.9B, the solution 
sits on a platform in the middle of the each well in a 24-well sitting drop plate (Hampton 
Research).  Reservoir solutions were prepared with the crystallization reagent.  Each 
crystallization drop contained 2 L of reservoir solution, 4 L lysozyme stock solution 
and 2 L of nanoparticle sample or DI water. The well plates were then sealed with tape 
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and placed in a temperature controlled environment (10 ºC ± 1ºC) and allowed to 
crystallize.  
2.3.3.3. High Throughput Crystallization Method  
*High throughput experiments run on the Gryphon Robot were programed and executed 
with the help of Kasia Walkiewicz, in the Shamoo Lab.   
A high throughput robot (ARI Gryphon) was used to prepare sitting drop well plates with 
96 crystallization conditions for quick screening of proteins in an array of potential 
crystallization conditions to determine which set of conditions promote crystal formation.  
Protein stock solutions without and with nanoparticles were automatically dispensed into 
small volume, 3-position, sitting drop, 96-well plates prepared with one of two set of 
conditions: Index Screen (Hampton Research) or PEG SuiteI (QIAGEN). The robot was 
programmed to deliver 0.3 L reagent (taken from the screen solution) and 0.3 L of the 
protein sample into each divot. After the samples were dispensed the well plates were 
sealed with optically clear tape and placed in a temperature controlled environment (10 
ºC ± 1ºC).  Each condition was evaluated based on the number of conditions that produce 
crystals, precrystallization materials (i.e. sheets, blobs or microcrystals) and/or 
aggregation.  
2.3.3.4. Batch method:  
For batch method crystallization the buffer, salt, protein and any additives (nanoparticles) 
were mixed together in larger volume solutions between 100 L and 100 mL, depending 
on the container.  This method was most appropriate for analysis of the crystallization 
process because the larger solution volumes produced more crystals. Containers were 
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selected that could be sealed tightly and hold the desired amount of solution; most 
commonly 100 - 200 L batches were prepared in 96 well plates, 1 - 3 mL batches were 
prepared in either 1.5 mL centrifuge tubes or 4.5 mL cuvettes (shown in Figure 2.9C) and 
10 mL batches were prepared in 15 mL centrifuge tubes. Larger samples were made in 
cell culture flasks or media bottles.  Crystallization reagents included a 0.1 M acetate 
buffer, pH 4.6, and 1 M NaCl solutions similar to those used for the hanging and sitting 
drop methods.  The only differences for the batch method crystallization are (1) that 
proteins and nanoparticles are combined together initially and (2) lower protein 
concentrations are used (2 – 8 mg/mL as compared to 25 mg/mL).  
Typically, nanoparticle concentrations of 3.8 nM were used in batch methods, unless 
otherwise stated.  The order materials were added into the solutions was important to 
keep nanoparticles and proteins from aggregating; first the buffer and water were 
combined, then the protein solution was added, followed by the nanoparticle solution and 
finally the salt solution. Solutions were mixed thoroughly until refractive index lines 
from the salt were no longer visible and the mixture appeared uniform to the naked eye. 
Samples were then sealed and placed in a temperature controlled environment (10 ºC ± 
1ºC) for at least 12 hours.  Most of the crystals settle to the bottom of the container during 
this time, but some cling to the sample walls. Gentle centrifugation was used to dislodge 
these wall-attached crystals.  
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Figure 1.16. Crystallization Methods. 
 
Crystals formed via the three methods: hanging drop, sitting drop and batch method, 
usually differed in concentration, size and rate of formation. Figure 2.10 shows optical 
microscope images for all three methods; hanging drop (A), sitting drop (B) and batch 
method (C).  Hanging drop crystals were typically larger and less abundant. Sitting drop 
method typically formed crystals quicker than hanging drop and produced slightly more 
crystals that were about the same size. The batch method produced the most crystals, 
smaller in size and typically faster than either of the other techniques. 
The three methods of crystallization are hanging drop, sitting drop and batch 
method. (A) Hanging drop the protein is suspended in a liquid droplet above the 
crystallization reagent reservoir on a cover slip and the well is seal with silicone 
grease. (B) Sitting drop the protein solution is sitting on a pedestal in the middle of 
the reservoir and sealed shut with tape. (C) Batch method mixes the protein and 
crystallization reagent in one solution and is sealed with tape. 
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Figure 1.17. Protein Crystals. 
 
2.3.4. Purification of crystals:  
Purification allowed the crystals to be separated from residual protein and nanoparticles 
in solution.  Gentle centrifugation using slow speeds, up to 10K RPM for 60 seconds 
provided a collection of crystals at the sample bottom; faster speeds can crack or damage 
the crystals.  The crystal pellet was rinsed with fresh crystallization reagent; use of other 
solvents could dissolve or destroy the crystals.  Purification was performed three times to 
ensure free protein was removed and crystallization was stopped.   
(Top row) Typical crystals formed via each method: (A) hanging drop, (B) sitting 
drop and (C) batch method. (Bottom row) Experimental setup for each method:  
(D) hanging drop, (E) sitting drop and (F) batch method. 
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2.3.5. Crosslinking of crystals:   
To provide more stable crystals for x-ray diffraction and imaging, the crystals were cross-
linked using 2-3% gluteraldehyde (Sigma – Aldrich, grade I) in fresh crystallization 
reagent overnight.  Crosslinked crystals could be cleaned repeatedly using Millipore DI 
water to remove crosslinking materials, buffer and salt from solution.   
2.3.6. Embedding crystals in resins:  
To examine sections of the crystals via TEM and SEM, the clean and crosslinked samples 
were prepared in a resin and cut on a microtome.  Three types of resins and molds were 
evaluated for embedding protein crystals.  Resins tested consisted of a photo-crosslinked, 
a thermally crosslinked (Ted Pella), and a highly cross linked acrylate and methacrylate 
based embedding media (Electron Microscopy Sciences).  These three were selected 
because they cure in less than 2 days and were reported to be inert to the gold 
nanoparticles.  The photo-crosslinked resin did not cure uniformly under UV light; after 
four days the external surfaces were hard but the interior was malleable and not suitable 
for clean sectioning. The thermally crosslinked resin did cure uniformly.  However, the 
heat either dissolved or otherwise disrupted the crystals.  Only the acrylate and 
methacrylate based embedding resin fully cured into a hard material without destroying 
the embedded protein crystal.   
The mold shapes were chosen to optimize the cured sample homogeneity and fit within 
the microtome sample holder. In general, flat molds ~0.1 cm high and less than 1 cm 
wide, cure the fastest and fit the best in the microtome sample holder, but the crystals are 
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all isolated at the bottom of the mold and more difficult to access for cutting.  A small 
cone shaped mold took a little longer to cure, but the crystals collected in the tip making 
it easier to both load and section on the microtome. 
2.3.7. Microtome:  
A Lewicka Ultramicrotome with a glass blade was used to sections crystals.  The resins 
containing nanoparticle-protein samples were mounted on the microtome and excess 
resin was trimmed away from the crystal leaving a 1 mm X 1 mm square area for 
sectioning.  A reservoir boat was affixed to the end of the blade with nail polish and filled 
with water.  Sections were cut at speeds not greater than 10 mm / sec and at thickness < 
200 nm (typically between 50 – 100 nm). A ribbon of sample was produced after multiple 
cuts and this was transferred to TEM 300 mesh copper grids by submerging the grids in 
the water and scooping the sample off the surface.   
2.4. CRYSTAL CHARACTERIZATION 
2.4.1. Kinetics of crystal formation:  
The method used to determine the kinetics of lysozyme crystal formation was modified 
from a method reported by Bessho et. al.. This approach monitored the change in protein 
concentration via optical absorbance during crystallization in real time (from 1 to 5 days) 
using a Cary 5000 UV/Vis.
21
  Batch method crystallization solutions were prepared in 4.5 
mL cuvettes which were housed in a 6x6 peltier temperature controlled autosample 
holder (Varian). Scanning kinetics software was used to obtain absorbance scans from 
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220 nm to 800 nm during the course of the experiment, the frequency of collection was 
set to increase with time: every 15 minutes for the first 6 hours, then every 30 minutes out 
to 12 hours, followed by once an hour out to two days and once every 2 hours for the 
remainder of the evaluation.   
Figure 2.11A shows the absorbance spectra collected from 250 to 800 nm, on a protein 
and nanoparticle sample.  Protein concentrations are typically monitored at 280 nm, 
however at the concentrations used for crystallization absorbance the signal at 280 nm 
saturates the detector and does not have a linear concentration dependence (Figure 
2.11B), therefore the absorbance at 301 nm was monitored to determine protein 
concentration, and the absorbance peak at 523 nm was monitored for nanoparticle 
concentration. Real time detection of the change in concentration over time provided a 
measure of the crystallization processes including the induction, nucleation, growth and 
equilibration phases; Figure 2.11C shows these regions in green, blue, purple and red, 
respectively.  
Initially, the solution has no change in optical absorption and this is generally referred to 
as the induction phase.  At the nucleation time (Tnuc), the concentration of protein in 
solution begins to decrease and what follows is a steady decline indicative of the growth 
phase.  For our evaluation Tnuc is taken to be the intersection of the where the linear fits 
for the induction phase and the growth.  Figure 2.11D shows the change in the optical 
absorbance for lysozyme at 5, 10 and 20 °C, which results in Tnuc values of 150, 1700, 
3970 minutes, respectively. 
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Figure 1.18. Kinetics of Crystal Nucleation Method. 
 
(A) Absorbance peaks at 280 nm (blue), 301 nm (green) and 523 nm (red) decrease 
as the sample is diluted. (B) Linear absorbance change with concentration show 
that the protein concentration can be determined from the absorbance at 301 nm 
(green line) and the nanoparticle concentration can be monitored with a peak at 523 
nm (red line). (C) The plot of protein concentration over time is used to determine 
the four phases of crystallization are: Induction (green), nucleation (blue), growth 
(purple) and equilibration (red). (D) Lysozyme crystallization monitored at three 
different temperatures 5, 10 and 20 °C. 
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2.4.2. Phase maps:  
Phase maps are designed to monitor the solubility of a protein under a wide variety of 
conditions so as to optimize the conditions that form crystals as opposed to 
precipitates.
22,23
 200 μL batch method crystallization samples were prepared in 96-well 
plates.  For the phase map in Figure 2.12, the lysozyme concentration was varied from 5 
– 60 mg/mL and ionic strength was varied from 0.5 – 4.0M, while keeping constant the 
buffer strength (0.1 M), temperature (10°C), pH (4.6) and the nanoparticle concentration, 
0 for Figure 2.12A, and 3.8 nM for Figure 2.12B.  Each well represents a unique 
condition which is classified at 1 hour after mixing as a (1) clear solution – blue square 
(2) precipitate / aggregated protein solutions – red square.  After 12 hours the samples are 
analyzed again for (3) crystal formation – black diamond. Figure 2.12 shows two typical 
phase maps for lysozyme without (A) and with nanoparticles (B).     
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Figure 1.19. Protein Phase Diagrams. 
 
2.4.3. Microscopy/Imaging:  
For hanging drop, sitting drop and small volume batch method crystals, images were 
obtained of the samples still in their original solution.  However, larger volumes of the 
batch method produced crystals had to be removed from solution and evaporated onto 
glass microscopy slides for imaging.  All images were obtained on an Olympus SZX16 
microscope fitted with a Q-Imaging Go-3 camera.  The images were capture and sized 
using QCapture Pro software. 
Two phase maps for the crystallization of lysozyme (A) without and (B) with 
nanoparticles.  
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2.4.4. Electron microscopy: 
 As-prepared, nanoparticle-protein crystals cannot withstand the high vacuum 
environments or intense electron beam irradiation.  Crystal samples had to be prepared 
for imaging via crosslinking, followed by sputter coating of a thin layer of platinum or 
gold  for SEM and microtome sectioning (See section 2.3.10. above) for TEM analysis.   
2.4.5. Scanning electron microscopy (SEM),  
* All SEM samples were sputter coated and imaged by Zuzanna Lewicka from the Colvin 
Lab.  I mounted each sample on the aluminum stub, was present for some of the imaging 
sessions and analyzed all the images. 
Cleaned, crosslinked crystals were evaporated onto aluminum SEM stubs (Ted Pella) and 
allowed to dry.  The samples were then coated with a thin layer (< 20 nm) of either 
platinum or gold, using a CRC-150 high voltage sputter coater.  Images were obtained 
using a FEI Quanta 400 ESEM operated at 20kV. Better retention of the crystals during 
imaging were seen in the samples that were adhered to the SEM stub with double sided 
carbon tape. 
2.4.6. Transmission electron microscopy (TEM):  
Clean, crosslinked crystals were prepared for TEM imaging either by growing very small 
crystals, smashing or cutting larger crystals.  Images of thick crystal samples on the TEM 
were obtaining using high angle angular dark field (HAADF) images in the scanning 
transmission electron microscopy (STEM) mode.  
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Figure 1.20. Imaging Lysozyme Crystals. 
 
Images obtained using (A) optical microscope 2X, (B) 4X, (C) SEM 200X, and (D) 
TEM 60KX. All scale bars = 200 m, except D = 200 nm. 
 73 
 
2.4.7. Single Crystal Diffraction  
*All single crystal diffraction data was collected and processed by Kasia Walkiewicz 
from the Shamoo Lab.  All sample preparation and mounting of the crystals was done by 
me.  
Uncrosslinked crystals were analyzed on a Rigaku cryo-beam X-ray diffractometer at 
50kV and 100mA.  Single crystals were mounted on a loop and then dipped in a cryo-
protectant glycerol solution; 30% glycerol solution and crystallization reagent (0.1 M 
Acetate buffer pH 4.6 and 1 M NaCl).  The crystal was then mounted in the beam line, as 
shown in Figure 2.14A and placed 120 cm from the detector.  Cu k radiation 
(=1.5406) radiation was used for collection of diffraction data at every degree from 0 – 
90º. Typical data is shown in Figure 2.14C.  
 
Figure 1.21. Diffration 
 
 (A) Crystal set up for single crystal or (B) powder diffraction. Typical data, (C) for 
a single crystal pattern is a series of dots, and (D) for powder XRD the patterns are 
sets of rings. 
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2.4.8. Powder XRD  
*All in-house powder XRD collections were run by Carolina Avendano or Arjun Prakash 
from the Colvin Lab.  They also provided help analyzing the peak positions and sample 
data.  
Clean, crosslinked and dried crystals were run on either a Rigaku D-Max Ultima-II 
powder XRD or on the 1-BM beam line at the Advanced Phonton Source at Argonne 
National Laboratories.  Data was collected on the Rigaku instrument at 40 keV and 40 
mA using a zero background sample holder and a Cu k radiation (=1.5406). Scans 
were collected for 7.5 hours over a theta range of 1 - 90º.  Jade 8.5 software was used to 
match expected gold peaks and find the d-spacing for lysozyme crystal peaks. APS 
powder diffraction patterns are collected on ground crystal samples mounted in 0.7 mm 
Kapton capillaries with filters (shown in Figure 2.14B), using the 1-BM line run at 20keV 
with 60 second exposures the data was collected from 0.6 – 35º.  Typical powder 
diffraction data is a series of rings as shown in Figure 2.14D. 
2.4.9. UV/Vis: 
 Absorbance data for solid protein crystals were collected for an ensemble or a single 
crystal.   
2.4.9.1. Solid ensemble:  
Ensemble data was collected on a set of clean, crosslinked crystals dried onto a glass 
microscope slide, which was affixed to the Varian Cary 5000 using an appropriate 
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aperture which blocks excess beam and holds the sample in place for measurement; care 
must be taken to apply enough sample to obtain absorbance and not too much to 
completely block the beam.  The same size aperture and a clean glass slide were also 
placed in the reference beam line.   
2.4.9.2. Single crystal polarization dependent absorbance,  
* All single crystals polarization dependent absorbance data and pictures were acquired 
by Lindsey Anderson in the Hafner Lab.  I prepared all samples and participated in 
finding an appropriate crystal to analyze.  
Single crystal absorbance spectrum was collected with an epi-illumination dark field 
microscope (Zeiss Axiovert 200M) equipped with a rotatable polarizer placed in the 
scattered beam path. Spectra were obtained with an imaging spectrograph (SpectraPro 
150, Princeton Instruments). For composite crystals containing gold nanorods, spheres or 
bipyramids the spectral properties were measured as a function of polarization angle for 
different areas on the crystal through a 10 micron slit. For each wavelength monitored, 
the detector dark counts were subtracted from the signal then the signal from the crystal 
was normalized to the background. 
2.4.10. Magnetization – SQUID 
* All SQUID data was acquired and processed by Chris Jones or Carolina Avendano 
from the Colvin Lab. 
Composite crystals containing magnetic nanoparticles were measured using a 
Superconducting Quantum Interference Device (SQUID) (Quantum design). Clean, 
crosslinked crystals were dried out of solution and housed in a plastic tube.  Analysis was 
run to collect hysteresis loops at 300K and 5K as well as the ZF/FC curves for samples 
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with and without nanoparticles present.  These properties were compared to the unbound 
nanoparticles free of protein crystals. 
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Chapter 3 
MEASURING POLYMER GRAFTING DENSITY ON 
NANOPARTICLES: ANALYTICAL 
ULTRACENTRIFUGATION AND TOTAL 
ORGANIC CARBON ANALYSIS 
 
Proteins interact with the surfaces of inorganic nanoparticles.  For nanoparticles 
stabilized in biological media, these interfaces are defined by the polymeric coatings 
attached to nanoparticles.  These coatings ensure steric stabilization, and thereby prevent 
nanoparticle aggregation.  These coatings also mediate protein-nanoparticle interactions, 
and to understand and control these interactions requires detailed information about the 
polymer structure.  Of particular importance in this work is the concentration of polymers 
*Work performed within this chapter was performed by myself with some addition 
help from interns in the Colvin lab: Raymond Verm (DLS evaluation), Michael 
Lilierose (grafting density effects: sample preparation and stability evaluation), and 
Naushaba Ali (TOC evaluation).   
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at the interface, a parameter commonly referred to as the grafting density.  Quantitative 
analysis of this parameter while nanoparticles are dispersed in solution is a significant 
measurement challenge.  In this Chapter we introduce methods to apply both analytical 
ultracentrifugation as well as total carbon analysis to the problem.  We compare the 
results from both approaches for a wide range of gold nanoparticle diameters as well as 
tethered polymer chain lengths, and validate these data using a solid state measure of 
total carbon content.  We also illustrate how the information can be used to monitor the 
grafting of polymers onto particle surfaces, as well as discern trends in the equilibrium 
grafting density with particle diameter and polymer chain length. 
3.1. INTRODUCTION 
The number of bound polymers per surface area (grafting density) is a critical feature to 
control when designing nanoparticles for biological or environmental applications; this 
parameter directly affects the hydrodynamic diameter and colloidal stability of 
nanoparticles – factors crucial in biological and environmental applications.1-11  Liu et al, 
for example, found 10 nm gold particles partially coated with polymer aggregated in a 
dilute salt solution.  However, when the surfaces were fully covered, corresponding to 
grafting density of 50 chains/particle, the sample was stable in a 1 M NaCl, solution.
1
  
Others have noted the relationship of nanoparticle grafting density to biological behavior.  
Biodistribution studies of poly(ethylene glycol) (PEG) coated nanocapsules found a 
strong correlation between circulation time and grafting density.  Fully coated materials, 
for example, had longer blood circulation times and reduced clearance by the liver, 
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spleen and kidneys as compared to materials which had 20% less surface-bound 
polymer.
2
 This same factor influences a nanoparticle’s transport through environmental 
matrices such as sand and water.  When uncoated iron oxide nanoparticles were passed 
through a sand column only 30 cm long, 99% of the material was retained.  In contrast, a 
partial coating of poly(acrylic) acid resulted in only 82% column attachment and an even 
more complete coating led to less than 50% column retention.
3
   
These examples illustrate that qualitative measurements permit the distinction between 
higher grafting densities and lower grafting densities; however, more quantitative 
methods to define the actual number of polymers at a nanoparticle interface are not 
generally available.  Theoretical estimates for the equilibirum or full coverage saturation 
grafting density can be found by assuming a particular size for polymers at a nanoparticle 
surface, and then deducing the theoretical grafting density at saturation using the 
available surface area of the core particle.
3,8,12
  
Experimentally, approaches to this problem have relied either on the measurement of 
total carbon content in a solid nanoparticle-polymer sample (e.g. thermogravimetric 
analysis TGA) or on spectroscopic methods to indirectly assess coverages  TGA is 
currently the gold standard but it requires large amounts of dried sample (> 1 mg).
6,8,13-16
 
Recently, a quartz crystal microbalance (QCM) was adapted for TGA of micrograms of 
powder and this may expand the application of TGA.
16
  Spectroscopic methods rely on 
quantification of signals from the surface bound polymers to deduce coverages.  For 
example, X-ray photoelectron spectroscopy (XPS) and nuclear magnetic resonance 
spectroscopy (NMR) can provide semi-quantitative assessment of grafting densities near 
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full coverage of polymers.
10,17-19
  Alternatively, a labeling method can be used to displace 
fluorescent molecules at a nanoparticle surface and detect net quantum yield.  These 
methods are difficult to generalize broadly both because they depend on the position and 
nature of the surface polymer features, and at least in the latter case are limited to only 
those particles that do not quench fluorescence. 
8,20,21
  
Here we address the challenge of nanoparticle surface characterization in solution by 
applying two techniques, analytical ultracentrifugation (AUC) and total organic carbon 
analysis (TOC), separately, to the measurement of the grafting density of gold 
nanoparticle-poly(ethylene) glycol conjugates.  For these materials the surface polymers 
are added to the sample in a ‘grafting-to’ approach that makes estimates of surface 
coverage difficult particularly for low coverages of polymers.  This problem prompted us 
to apply both AUC and TOC to the analysis of small volumes of nanoparticle solutions 
with the aim of extracting quantitative measures of the number of polymers bound to a 
particle.   
We applied each method to a range of polymer chain lengths (1,000 to 20,000 molecular 
weights), polymer concentrations (8.5 nM – 8.5 μM) and a series of gold nanoparticles 
diameters (8 to 27 nm).  First, the grafting density measured from both AUC and TOC 
over this wide range of conditions were within 30% of each other.  Moreover, these 
results matched well to the values found from thermo-gravimetric analysis of dried 
milligram quantities of the same samples.  Polymer concentrations as low as ten PEG per 
particle produced discernible changes in the surface coverage and both methods 
accurately detected changes in grafting density of less than ten percent.  Conventional 
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thermogravimetric analysis is not sensitive enough to measure such small changes in 
polymer concentrations.  
We used these tools to investigate several solution phase phenomena of both partially and 
completely coated nanoparticles.  First, the aggregation behavior of gold nanoparticle-
polymer conjugates in high ionic strength solutions was correlated quantitatively to the 
grafting density at the surface. As the polymer concentration in a sample increases, 
imparts steric stability which prevents the gold nanoparticles from aggregating. 
Interestingly, the nanoparticles can be stabilized in a monovalent salt solution with half 
the polymer concentrations needed for saturation using a high molecular weight polymer, 
but require an excess of 80% with a low molecular weight polymer coating. Second, we 
examined the trends in the saturation coverage as a function of chain length and particle 
size.  Polymer grafting density decreased substantially as chain lengths increased for all 
nanoparticles sizes. In addition, the grafting density of low molecular weight PEG 
increases with increasing particle diameter.  
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3.2. GRAFTING DENSITY CALCULATIONS:  
Scheme 3.1 Calculation flow diagram. 
 
3.2.1. TGA grafting density 
The grafting density (σ) from TGA was calculated using equation 1.  First the relative 
mass of the polymer (wt%shell) is normalized to the mass of the inorganic nanoparticle 
(wt%core); taken from the experimental residual percent mass at 500 °C. The polymer 
mass is determined based on this percentage assuming the density of gold in a 
nanoparticle is the same as that of bulk gold (ρcore = 19.6 g/cm
3
).  To convert this to the 
mass of a single particle, the volume is calculated assuming a spherical particle and the 
average radius found via TEM analysis (see Chapter 2.2.1). The number of polymers per 
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particle, Npoly, is determined by multiplying by Avogadro’s number (NA) and dividing by 
the polymer molecular weight (MWt).  The grafting density (σ) is found by dividing the 
polymer concentration per particle by the available surface area (4πr2, r from TEM).  
 
 
 
3.2.2. TOC grafting density 
Grafting density (σ) from TOC is calculated using equation 2.  The nonpurgeable organic 
carbon concentrations ([C]), reported as ppm in a TOC analysis, should first be converted 
to molarity (moles/liter) by dividing by carbon’s molar mass (12 g/mole).  Then the 
molarity of carbon is used to determine polymer concentration from applying the ratio of 
carbons per monomer unit (2 for PEG) and the number of monomers (n) in each polymer 
sample (e.g. the molecular weight or MWt) divided by the weight of one monomer (44 
g/mole for PEG).  To determine the ratio of PEG molecules per particle, first the molar 
concentration of nanoparticles in solution ([NP]) must be determined; it can be 
determined based the optical absorbance of the gold nanoparticle solution.
22
  Then the 
molarity of PEG is divided by the molarity of the nanoparticles, [PEG]/[NP]. The molar 
ratio of PEG molecules per particle once divided by the surface area of a particle (using 
the radius found using TEM) results in grafting density (σ). 
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Equation 3.1. TGA grafting density 
Equation 3.2. TOC grafting density 
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3.2.3. AUC grafting density 
This approach takes a different approach to measuring the surface coatings of particles.  
It relies on the change in density induced by the association of lower density particles 
with the very dense gold cores.  In effect, particles become less dense as more polymer is 
bound to them. This is quantified through measures of the sedimentation coefficient (s), a 
value related to particle density by equations 3 and 4.  Other parameters that are 
important to the definition of the sedimentation coefficient include the solvent viscosity 
(η) and its density (ρs) as well as the particle’s hydrodynamic diameter (dh).   While the 
first two parameters are easily obtained from the solvent itself (nanoparticle 
concentrations are too low to impact these values), the last parameter is challenging to 
measure particularly for undersaturated coatings. 
 
 
 
 
 
 
 
Equation 3.3. Sedimenation coefficient (AUC) 
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Equation 3.4. Particle density (AUC) 
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The volume of the shell (Vshell) is the polymer thickness times the surface area (4π rcore
 2
); 
where the thickness of the polymer layer is determined from the difference between the 
hydrodynamic radius (rh, from DLS) and the radius of the core (rcore, TEM).  The total 
density of the nanoparticle is the volume fraction of the core (Vcore, TEM) multiplied by 
the density of the core and the volume fraction of the shell multiplied by the density of 
the shell (equation 5).  Given the density of the nanoparticle (equation 2) and the density 
of the core; which can be determine theoretically or by AUC evaluation of an uncoated 
particle, equation 5 is rearranged to solve for the density of the polymer shell (equation 
6).  From there the mass of polymer equals the volume of the shell times the calculated 
shell density.  The mass is related to the number of polymers per particle using 
Avogadro’s number (NA) and the known molecular weight (MWt).  Finally, the number 
of polymer molecules is normalized by the available surface area of the core nanoparticle 
(4π rcore
 2
) resulting in the grafting density.  
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Equation 3.5. Density nanoparticle based on volume fraction (AUC) 
Equation 3.6. Density polymer shell 
(AUC) 
Equation 3.7. Mass polymer shell 
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3.3. RESULTS AND DISCUSSION 
3.3.1. Explanation of methods 
This work compares the application of analytical ultracentrifugation (AUC) and total 
organic carbon analysis (TOC) to nanoparticle solutions for measurement of the surface 
coverage of bound polymers.  We first introduce analytical ultracentrifugation which has 
conventionally been a tool for physical biochemists.
23,24
  Over the last ten years, however, 
it has found increasing use in nanotechnology for the evaluation of size and size 
distribution of various nanocrystals; the bioconjugation of gold nanoparticles; and the 
surface structure and surfactant coating materials on carbon nanotubes.
25-32
 AUC finds a 
sedimentation coefficient for every nanoparticle-polymer sample; this parameter depends 
sensitively on the overall nanoparticle-polymer density.  If the hydrodynamic diameter of 
the overall nanoparticle-polymer can be accurately measured, this density can be used to 
determine the surface coverage of polymers.  
Figure 3.1 illustrates how the sedimentation coefficients (e.g. s-value) vary for 
nanoparticle-polymer conjugates at saturation coverage.  Data was collected as a function 
of core nanoparticle size (7.5 to 25.5 nm, panels A-D) as well as polymer chain length 
(1K to 20K MWt, panels E-F). TEM micrographs in Figure 3.1 show 7.5, 11.7, 19.9 and 
coreA
shell
AUC
rNMW
m
24



Equation 3.8 AUC grafting density 
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25.5 nm diameter gold particles. AUC velocity sedimentation experiments run on each of 
these samples have increasing sedimentation coefficients (288 ± 7, 617 ± 15, 1697 ± 35 
and 3359 ± 87 Sv) with increasing core diameter (Figure 3.1E).  This trend is captured 
quantitatively in Figure 3.1F which illustrates the almost linear dependence on core 
diameter.  Figure 3.1G shows that the addition of a polymer coating to the gold 
nanoparticles results in a decrease in their sedimentation coefficient; longer polymers 
have more of an effect on sedimentation.  Figure 3.1H shows this relationship graphically 
as the molecular weight of the surface-bound polymer changes from 1K to 20K.     
 
Figure 3.1 Analytical ultracentrifugation 
 
Analytical ultracentrifugation (AUC) characterization of nanoparticles based on 
size and density.  Transmission electron micrographs taken on four batches of gold 
nanoparticles reveal core diameters of (A) 7.5 ± 1.9 nm, (B) 11.7 ± 1.4 nm, (C) 
19.9 ± 1.9 nm, and (D) 25.5 ±  1.8 nm (scale bars = 100 nm). Sedimentation 
coefficient distributions measured via AUC show an increase as a function of the 
diameter (E&F). Samples of B coated with PEG with increasing molecular weights, 
from 1K to 20K, show a decrease in the sedimentation coefficient distributions due 
to a decrease in the overall particle density (G and H). 
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The sensitivity of the sedimentation coefficient to the core size and the surface polymer 
chain length derives from its relationship to both hydrodynamic diameter and overall 
conjugate density (see equation 1.3 above).  By measuring the hydrodynamic diameter 
(HD) from DLS, and with known solution parameters such as solvent density and 
viscosity, it is straightforward to calculate the nanoparticle-polymer conjugate density. 
This data is reported in Table 3.1; nanoparticle-polymer conjugates have lower density 
than bulk gold due to the presence of the organic coatings.  If the volume of the polymer 
shell is calculated from the hydrodynamic data, it is then possible to calculate the net 
mass of the polymer layer and thereby arrive at the number of surface associated 
polymers.   
 
Table 3.1. Characteration of polymer coated nanoparticles based on  
density using AUC and DLS. 
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As an example, consider the 2K and 20K MWt PEG coated samples for 9.1 nm gold 
particles, which has a sedimentation coefficients of 586 ± 46 Sv.  The 2K MWt PEG 
coated sample shown in figure 3.2A has a core diameter of 9.1 nm and a polymer 
thickness of 4.2 ± 0.4 nm (85.9% of the total volume). Using the overall particle density 
of 3.0 ± 0.3 gm/cm
3
, this corresponds to a polymer mass of 1.7 E
-18
 ± 0.2 E
-18
 gm, and a 
grafting density of 1.9 ± 0.2 PEG/nm
2
.   In contrast the larger PEG MWt coating had a 
thickness of 35.5 ± 0.5 nm (99.9% of the total volume). The overall density of this 
particles 1.0 ± 0.0 gm/cm
3
, this corresponds to a polymer mass of 9.4 E
-18
 ± 0.8 E
-18
 gm 
and a grafting density of 1.1± 0.0 PEG/nm
2
.     
The other approach used here to measure grafting density relies on changes in the sample 
composition as measured by total organic carbon, TOC, analysis.  This method is in 
principle very similar to thermogravimetric analysis which measures the carbon in a solid 
powder from its combustion products; however, TOC measures in the solution phase and 
on small liquid samples, a single injection can use as little as 50 microliters.  In solution, 
catalysts are used to promote organic carbon decomposition into CO2 which is quantified 
to determine the total carbon in solution.  Alternately, pretreating a sample with acid and 
purging with an inert gas the inorganic carbon is removed and the remaining carbon 
detected is the non-purgeable organic carbon (NPOC), this is used to measure the 
polymer carbon concentrations.  Figure 3.2B shows that at equilibrium saturation (e.g. 
full coverage) the carbon concentrations increases with polymer chain length. 
Converting the measured carbon concentrations from ppm carbon into the nanoparticle-
polymer grafting densities is relatively straightforward. It requires an accurate measure of 
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nanoparticle concentration, derived here from absorbance data (see materials and 
methods section 2.2.3). The grafting density is then the ratio of available surface area (per 
volume) to the number of PEG molecules derived from the carbon concentration and the 
molecular weight of the PEG. As an illustration, a 9.0 nM solution of 2K MWt PEG-gold 
(9.1 nm d) had a carbon concentration of 9.4 ± 0.3 ppm and a corresponding grafting 
density of 2.5 ± 0.0 PEG/nm
2
.   The most significant source of systematic error is the 
underlying assumption that all measured carbon is derived from surface associated 
polymers.  Careful sample purification ensures that this concern is minimal (See Chapter 
2.1.2; purification).  
Table 3.2. Characteration of polymer coated nanoparticles based on 
carbon content. 
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Figure 3.2 Effects of PEG coatings 
 
3.3.2. Validation of methods 
Finally, to validate both methods, we applied thermogravimetric analysis to powders 
derived from the nanoparticle solutions.  This tool measures total carbon and is thus 
similar to the total organic carbon analysis, but it requires large amounts of solid material 
as opposed to liquid solutions.  Figure 3.2C shows that the percent mass loss between 150 
Analysis of poly(ethylene) glycol coatings of 2K (red) and 20K (blue) on ~10nm 
inorganic gold nanoparticles. (A) AUC evaluations showed decreased 
sedimentation coefficient distributions with increased polymer molecular weight. 
The organic polymer adds carbon to the sample which raises the carbon 
concentration found using (B) total organic carbon analysis, and (C) increases the 
mass loss below 500°C determined via thermogravimetric analysis. (D) Each of 
these measurements can be used to quantify the polymer grafting densities. (Some 
error bars are not larger than the line).   
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and 500 °C increases with surface functionalization and again with increased molecular 
weight of PEG. TGA is used extensively in nanotechnology for the evaluation of surface 
coatings on inorganic nanomaterials; data can provide information about whether a 
coating is present, as well as the grafting density and sample purity.
6,13,15,16,33,34
 TGA 
analysis houses samples on precision balances in a furnace then the weight is collected as 
a function of temperature. For our samples the temperature was ramped from 150 to 1200 
°C and all of the mass loss between 150 and 500 °C is attributed to the polymer. The 
weight percent of the polymer, from TGA and the core diameter of the particle, from 
TEM are used to determine the polymer grafting densities from TGA data, shown in 
calculation flow diagram 3. For the 2 K PEG coated gold, 20.8 ± 0.0% of the sample 
weight is polymer and has a resulting grafting density of 2.3 ± 0.0 PEG/nm
2
.  The largest 
systematic error for TGA is that oxidation of the inorganic materials can occur and result 
in an underestimation of the organic fraction of the materials. 
Table 3.3 Nanoparticle and surface coverage and grafting density 
 
This standard tool, TGA, provided a measure of polymer surface coverage that was in 
reasonable agreement, within 30 %, of the values found from both AUC and TOC (Figure 
3.2D).  (see table 1).   The 2K nanoparticle-polymer conjugate had surface coverages of 
2.2 PEG/nm
2
 by TGA, which was in between the 2.5 and 1.9 PEG/nm
2
 found from TOC 
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and AUC respectively.  The longest polymer studied, 20,000 MWt, had grafting densities 
of 0.8 PEG/nm
2 
 as measured by TGA which was below the values found from TOC and 
AUC (1.2 and 1.1 PEG/nm
2 
respectively).  Interestingly, TGA provided carbon content 
consistently lower than the solution TOC methods.  As noted above, by measuring carbon 
in solution (TOC) any impurities lead to a systematic error that increases the determined 
grafting densities; in contrast, during the analysis on TGA the flow of air can lead to 
oxidation of the inorganic core particles which would result in overestimating the 
inorganic content and underestimating the carbon content; yielding smaller grafting 
densities. 
Also notable is the consistent agreement between the AUC and the TOC.  The differences 
were most pronounced for the shorter polymer chains; the 2K sample for example, was 
found to have a grafting density of 1.9 from AUC as opposed to 2.5 from TOC.  The 
grafting densities for the larger 20 K PEG, are within 0.2 PEG/nm
2
 (1.0 to 1.2 PEG/nm
2
). 
Aliquots from the same samples were run on both AUC and TOC to compare techniques 
over a wide range of polymer molecular weights and incomplete surface coverages 
(Figure 3.3). Five polymers coatings from 1K to 20K MWt on ~10 nm gold nanoparticles 
have grafting density values that deviate less than 38% between methods. In addition, 
samples with incomplete 2K PEG coating were prepared using PEG concentrations from 
8.5 nM to 8.5 μM have coverage measurements by AUC and TOC with values that lie 
within 17% of each other.  For all samples evaluate by both techniques there is an 
average difference of 20%.  
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Figure 3.3. Grafting densities 
 
All open squares are grafting densities values obtained using AUC and closed 
squares are values obtained from TOC data. Error bars represent measurements in 
triplicate for a single batch.  Measurements of grafting density agree across surface 
coating of five different PEG molecular weights and increasing polymer 
concentrations within a 40% deviation for any given sample, with and average 
agreement of 20%.   
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3.3.3. Applications of the measurement of surface polymer coverage 
These measurements make it possible to study how the surface associated polymer 
concentration varies with the amount of added solution polymer.  Current quantitative 
analytical methods to determine grafting density are not sensitive enough to evaluate the 
polymer surface coverage on nanoparticles below saturation. Figure 3.4 shows the 
systematic increase and eventual plateau in grafting densities as a function of initial 
polymer concentration from 8.5 nM to 8.5 μM for 2K and 20K PEG-SH coated gold 
nanoparticles.  Either method showed sensitivity in determining the grafting density with 
changes in polymer concentration less than 10%. Surface saturation concentrations for 
2K and 20K PEG were determined to be around 4 μM and 3 μM PEG for the samples, 
respectively.  These saturation concentrations are at coverages of 500 and 370 
PEG/particle, respectively.  
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Figure 3.4. Change in Grafting Density 
 
Figure 3.4 also presents colloidal stability data for particles as measured through their 
aggregation in the presence of various salts.  The minimum NaCl or CaCl2 concentration 
that result in the aggregation of the particles is known as the critical coagulation 
concentration (CCC).  This test has been applied frequently as an indirect measure of the 
effective surface coating of particles by associating stability in a salt solution with the 
The change in grafting density upon the addition of (A) 2 K or (B) 20 K PEG to a 
solution of ~10 nm gold nanoparticles (red dotted lines are added to guide the eye). 
The critical coagulation concentrations (CCC) of the (A) 2K and (B) 20K coated 
particles were determined with sodium chloride and calcium chloride.   
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full, equilibrium saturation of a particle.
1
  We evaluated critically this assumption using 
independent measures of the surface coverage.   
Apparent in Figure 3.4 is that particles can be rendered stable in solution even while their 
polymer surface coverage is not fully at equilibrium.  For example, CCC evaluations in 
NaCl find a stable sample at polymer concentrations of 2.1 and 0.85 μM PEG (300 and 
100 PEG/particle) for the 2 K PEG and 20 K PEG samples, respectively.  This should be 
the concentration where the polymer effectively blocks the surface charge inherent on as 
synthesised gold nanoparticles.  However, measurements by zeta potential found that 
slightly lower polymer concentrations of 1.3 μM (150 PEG/particle) 2K PEG and only 
0.6 μM (75 PEG/particle) 20K PEG neutralize the surface charge. By contrast, neither 
surface coating material has a resistance to aggregation in the divalent, CaCl2, solutions 
at low PEG concentrations and it is not until 2.6 μM PEG (300 PEG/ particle) 
concentration do the particles become stable in the divalent solution. Interestingly, this 
concentration (2.6 μM) is close to the polymer concentrations needed to reach surface 
saturation for both PEG chain lengths (4 μM and 3 μM).  These results suggest that the 
evaluation of the completeness of a surface coating is not accurately assessed through the 
stability in monovalent salt solutions or by the loss of effective surface charge.  The most 
effective tests for surface saturation are measurements of polymer grafting density or 
alternatively, through flocculation in a divalent salt solution.  
Measurements in the grafting densities also reveal interesting trends in polymer packing 
around nanoparticles.  Most notably is the fact that polymer conformation can be very 
different depending on the polymer chain length.  Saturated grafting densities 
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measurements for five polymers, from 1K to 20K, on seven particle diameters, from 8 to 
27 nm. Figure 5A shows, that as expected, grafting densities determined by AUC 
decrease as polymer molecular weight increase for all diameters of nanoparticles tested. 
This means that the shorter molecular weight PEG molecules occupy less surface area 
and can pack more efficiently than the larger molecular weight polymers.  Furthermore, 
the shortest polymer chain length has an increased packing efficiency with increased 
nanoparticle diameter.  As the nanoparticle diameter increases from 8 nm to 27 nm there 
is a corresponding increase in grafting density from 2.5 to 14.9 PEG/nm
2
 for 1K PEG.  
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Figure 3.5. AUC analysis of PEG coverages 
 
 AUC analysis of PEG coverages on various nanoparticle sizes. Particles from 8 nm 
to 27 nm, were evaluated with 1K, 2K, 5K, 10K and 20K PEG coverages showing 
that the polymer grafting densities decrease as polymer molecular weight increases 
for all sizes.  In addition there is an increase in packing efficiency for the 1K  low 
molecular weight PEG molecules as the particle diameter increases. X error bars 
depict the measured size distribution. (Most error bars are not larger than their 
corresponding data points) 
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3.3.4. Comparison of analytical methods  
This work presents two options for solution-based assays that can easily and reproducibly 
measure the polymer coverages of nanoparticle-polymer conjugates directly in aqueous 
solutions.  Both AUC and TOC are performed in the native solutions and use less than 1 
mL (< 60 μg) of sample for a triplicate evaluation and thus have a distinct advantage as 
compared to the sample intensive TGA methodology (See table 3.4 below).  AUC has the 
advantage that it can be applied to variety of surface functionalized materials even in 
non-aqueous solvents.  It is also insensitive to the presence of carbon-containing 
impurities.  While in this work DLS was required as an independent measure of 
hydrodynamic diameter, we note that using 2D velocity sedimentation analysis it may be 
possible to get both the sedimentation coefficient and hydrodynamic diameter in one 
scan.
35
  However, the instrumentation is more specialized and data analysis can be 
difficult.  TOC, on the other hand, is a simple bench top instrument with easy sample 
preparation and data analysis, and thus more likely to be adopted in routine laboratory 
use.  Another possible benefit of the TOC is that it can be fitted with a total nitrogen 
module for simultaneous quantification of carbon and nitrogen which would be valuable 
for analysis of surface coating materials with amine functionalization groups.  However, 
TOC can be prone to overestimating the surface coverages if solutions are not carefully 
purified.   
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Table 3.4. Comparison of techniques. 
 
3.4. CONCLUSION 
In summary, we have determined that analytical ultracentrifugation and total organic 
carbon analysis are effective methods for obtaining the polymer grafting densities of 
nanoparticle-polymer conjugates directly in solution.  Both techniques were used to 
evaluate a range of gold nanoparticle diameters coated with various molecular weights of 
thiol functionalized poly(ethylene glycol). Dilute (~10 nM)  samples of less than 1 mL 
were analyzed for polymer surface coverage; not only did each method independently 
agree, but their reported values were consistent with those derived from 
thermogravimetric analysis of the carbon content of recovered powders.  AUC is best 
suited for samples with dense and uniform core nanoparticles, and may be applied to 
nanoparticles in any kind of solvent.  It does require a specialized instrument capable of 
relatively intensive data analysis for extracting sedimentation coefficients.  Measures of 
total organic carbon use a benchtop and simple instrument and are clearly superior for 
aqueous suspensions that have been carefully purified. These approaches to measuring 
the polymer surface coverage of nanoparticle-polymer conjugates offers many 
advantages to researchers.  These include quality control methods to ensure batch to 
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batch consistency, as well as quantitative assessments of the role of surface coverage on 
engineered material’s stability and transport in biological or environmental matrices.   
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Chapter 4 
NANOPARTICLE-POLYMER CONJUGATES AS 
NUCLEANTS FOR PROTEIN CRYSTALLIZATION 
 
Nanoparticles possess many properties which suggest they could be appropriate 
nucleation sites for protein crystals.  They can be appropriately stabilized to interact 
either strongly or weakly with individual proteins, and could thus act as heterogeneous 
nucleants for crystallization.  To evaluate this hypothesis, polymer–nanoparticle 
conjugates (thiol functionalized poly(ethylene glycol) (HS-PEG) on gold) were used in 
protein crystallization studies.  The PEG coatings provided steric stability to the 
nanoparticles and allowed them to remain individually dispersed even in the high ionic 
*Work performed within this chapter has been done in collaboration with members 
from Dr. Shamoo’s lab. All training and support for crystallization methods were 
provided by Kasia Walkiewicz, and Dr. Milya G. Davlieva.  They also ran and process 
the single crystal diffraction data and programed and ran the high throughput robot.  In 
addition I had a lot of help from interns in the Colvin lab: Ajoke Williams 
(development of crystallization kinetics methods), Gustavo Resendiz (crystallization 
of proteins other than lysozyme), Raymond Verm (method development work for 
kinetics and dialysis equilibrium studies), Michael Lilierose (nanoparticle stability and 
dialysis studies), and Naushaba Ali (nanoparticle characterization and equilibrium 
dialysis studies).   
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strength of the crystallization growth medium. The polymer coatings also served to 
mediate the strength of interaction between the nanoparticles and the proteins.  Shorter 
chain poly(ethylene) glycol effectively blocked all protein interactions.  Longer chain 
polymers, with molecular weights larger than 5,000, were able to weakly associate with 
proteins.  Crystal formation in the presence of these nanoparticle-polymer conjugates was 
notably faster for a diverse set of proteins, such as ferritin, human serum albumin, lipase 
B, xylanase, glucose isomerase and lysozyme.  In all cases the nanoparticle nucleants 
decreased the time to nucleation, expanded the range of appropriate crystallization 
conditions, and increased the success rate for producing crystals and pre-crystalline 
materials in high through-put crystallization.  
4.1. INTRODUCTION 
The identification of protein structure remains central to the study of both biology and 
medicine.  When biomedical researchers have the full tertiary structure of a protein it is 
possible to design molecular drugs for precise interactions with active sites within the 
protein, this is called structure based design.  Additionally, our exanded understanding of 
genetics brought about by the human genome project has made it clear that a full 
understanding of systems biology requires better and faster methods to characterize even 
greater numbers of proteins and their modifications – now a task for the Human Proteome 
Project.
1,2
  
A significant barrier faced in these areas is the rapid and reliable analysis of protein 
structure – a process that requires protein crystallization followed by x-ray 
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crystallography.   While thousands of proteins have been analyzed in this fashion, there 
are many thousands more that lack successful crystallization protocols.
3,4
  Researchers 
have traditionally used trial and error to develop conditions that lead to a protein’s 
crystallization, but this approach is slow, only modestly successful and dependent on 
large quantities of pure protein.
1
  Recently, high-throughput and automated screening 
methods have vastly expanded the speed and consequently the number of crystallization 
conditions that can be evaluated.  However, the success rate for these high-throughput 
methods, termed the ‘hit rate’, remains low and for many systems can require months of 
development.
1-6
 In many cases protein and protein-ligand complexes of great importance 
remain unsolved even after years of decades of effort. 
As a result of these challenges, there has been a longstanding interest in the development 
of nucleating agents for protein crystallization. Protein crystals usually form in solutions 
that are just barely supersaturated;
2
 in this way, crystals develop slowly and with more 
perfection providing substrates better suited for x-ray crystallography.
2,7,8
   However, 
entropic barriers to crystallization under such conditions are substantial.  Proteins are 
large dynamic molecules and they often possess many possible conformations that 
determine protein-protein associations.  As a result, the time to nucleation of protein 
crystals – referred to commonly as the induction time – can be in excess of one month.  
By incorporating a nucleation agent, generally referred to by the protein crystallization 
community as a nucleants, the hope is to drastically reduce the induction time to 
nucleation.   
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While many interesting materials have been found to induce nucleation for some 
proteins, the goal of a ‘‘universal nucleant’’ for protein crystallization remains elusive.2,9  
Early protein crystallographers relied on solid substrates such as horse hair and seaweed 
to induce nucleation or proteins; more recently porous substrates and bioglass have 
become a focal point.
2,9,10
 In all of these cases the nucleants are macroscopic materials 
and therefore not easy to introduce into current high-throughput crystallization 
instrumentation as they have to individually placed in each well for evaluation.  
While solid materials, nanoparticles can be stabilized in aqueous suspensions and 
incorporated directly into the protein stock solution.  Two previous studies have 
evaluated gold nanoparticles and polystyrene nanospheres in crystallization strategies for 
multiple proteins.  However, these nanoparticles quickly aggregated due to the screening 
of their surface charges, and it is likely that the proteins nucleated on the surfaces of 
larger aggregates of nanoparticles.
9,10
 An outstanding question is whether nanoparticles 
that are colloidally stable in crystal growth media, effectively acting as isolated materials, 
could induce protein crystal nucleation.
5
 
Here we show that sterically stabilized polymer – nanoparticle conjugates (AuNP_PEG) 
are stable in crystal growth media and that they promote the nucleation of many different 
proteins.  This effect is very sensitive to the polymer surface structure which is defined 
by its surface coverage and molecular weight.  Shorter polymer chains (2,000 molecular 
weight) extend around a nanoparticle and have very high surface coverages (e.g. 1.9 PEG 
chains/nm
2
) while longer polymer chains  (20,000 molecular weight) will mushroom and 
have lower net surface coverage (e.g. 1.1 PEG chains/nm
2
).   As discussed in Chapter 3, 
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it is the longer polymer chains that have the most protein association, and as shown in 
this Chapter the biggest impact on protein nucleation.  For example, 10 nm gold 
nanoparticles coated with longer polymers decreased the time to nucleation for lysozyme 
by a factor of seven, increased the hit rates for crystal formation in high-throughput 
screens, and allowed for protein crystallization below supersolubility conditions with 10 
million proteins per particle.   
In this Chapter we present the impact of polymer-nanoparticle conjugate incorporation 
into the protein stock solutions used in existing high-throughput screening techniques.  
Two concentrations of gold nanoparticle-polymer conjugates, 1 and 10 nM, were added 
to protein stock solutions for ferritin, human serum albumin, lipase B, xylanase, glucose 
isomerase and lysozyme.  The effects were characterized and evaluated based on results 
from two sets of 96 screening conditions for a total of 192 unique preparations.  With 
nanoparticles the number of conditions that produce crystals increased on average for all 
proteins by a factor of five (1 nM) and a factor of seven (10 nM).  Moreover, nanoparticle 
additions reduced the occurrence of unfavorable protein aggregation in many cases. 
Finally, adding nanoparticle nucleants to the lysozyme protein crystallization screens 
resulted in crystal formation in 26 conditions that without the nanoparticles had no 
crystals.  
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4.2. MATERIALS AND METHODS 
4.2.1. Nanoparticle preparation, characterization and purification 
(see Chapter 2.1.1.-2.1.2.)  
4.2.2. Protein stock solutions:  
Pure protein samples of lysozyme, ferritin, human serum albumin (HSA), (Sigma 
Aldrich) lipase B, xylanase, and glucose isomerase (Hampton Research) were prepared in 
buffered solutions where the protein concentration, buffer material, ionic strength and pH 
were determined from literature or from recommendations from the vendor.  
Concentrations were determined spectroscopically at 280 nm.  Solution concentration 
were as follows: Lysozyme (50mg/mL), ferritin (30 mg/mL), HSA (10mg/mL), lipase B 
(35 mg/mL), xylanase (18 mg/mL), glucose isomerase (10 mg/mL). For more 
information about the protein stock solution preparations see Chapter 2.3.2) 
4.2.3. Crystallization:  
Hanging drop, batch method and high-throughput crystallization methods were used as 
previously described (Chapter 2.3.3 Protein crystallization methods).  
4.2.4. Kinetics of crystal formation:  
The method to determine the kinetics of crystal formation was adapted from previous 
literature on lysozyme crystallization.
11
 Briefly, the protein and AuNP concentrations 
were monitored in real time during crystallization (from 1 – 5 days) to determine time to 
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nucleation (Tnuc), and concentration of materials in solution and in the crystal.  For more 
information about this process, please see Chapter 2, section 2.4.1, kinetics of crystal 
formation. 
4.2.5. Phase maps:  
Phase maps are used to determine the solubility region of a protein around a crystallizing 
condition to optimize the crystal formation. (See chapter 2.4.2) 
4.3. RESULTS AND DISCUSSION 
4.3.1. Forming sterically stabilized polymer-nanoparticle conjugates 
Polymer – nanoparticle nucleants were prepared by conjugating poly(ethylene glycol) to 
gold colloid. The red colored solution in Figure 4.1, displays the characteristic 523 nm 
peak optical absorbance spectrum expected from the 12 nm gold nanoparticles shown in 
the transmission electron microscopy image.  As produced gold nanoparticles are coated 
with a layer of negatively charged citrate molecules which keep particles isolated in 
solution due to repulsive forces.  However, these particles will quickly aggregate when 
ions are present in solution. Counter positive ions are attracted to the negative surface and 
in turn will attract more negative ions until there is a complete destabilization of the 
charge barrier that kept the particles isolated and they will begin to aggregate. The 
increase in particle size due to aggregation causes the peak optical absorbance of the 
sample to shift towards longer wavelengths, causing the once red solution to shift to a 
purple color which provides visual indication that the particles are unstable.
12,13
 To make 
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sure this doesn’t happen for the nanoparticle nucleants of interest in this Chapter, surface 
modification strategies are used to impart steric stability (as opposed to charge stability) 
to nanoparticles.
14,15
 
 
Figure 4.1. Gold nanoparticles. 
 
Figure 4.2A shows the polymer grafting scheme used in this work.  Thiol functionalized 
poly(ethylene glycol) (HS-PEG) exposed to gold nanoparticles in water binds to the 
surface via the strong gold-sulfur bond. The polymer layer depicted on the nanoparticle 
surface in Figure 4.2 is represented as an extended brush conformation; however based 
on surface coverage and molecular the polymer could assume either an extended brush 
(high coverage, low MWt) or a partially coiled mushroom (low coverage, high MWt) 
conformation. The polymer coating prevents aggregation through steric effects. Figure 
4.2B&C show that PEG coated nanoparticles are more resistant to aggregation in high 
(A) Gold nanoparticle solutions are characteristically red due to a strong optical 
absorbance peak in the visible region of the spectrum of light, centered at 520 nm. 
(B) Transmission electron microscopy image for the near spherical gold 
nanoparticles. (C) Histogram showing the size and distribution of 11.7 ± 1.4 nm. 
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ionic strength salt solutions.  At the conditions used for lysozyme crystallization, 1 M 
NaCl, the uncoated particles are aggregated, while the PEG stabilized sample remains 
disperse in solution.   
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Figure 4.2. Sterrically stabilized nanoparticles in lysozyme 
crystallization. 
 
(A) Gold nanoparticles coated with thiol functionalized poly(ethylene glycol) 
create polymer – nanoparticle conjugate nucleants.  PEG layers provide steric 
stabilization. (B) Uncoated nanoparticles aggregate at low concentrations of salt in 
solution, while (C) PEG coated nanoparticle are disperse in solution even at salt 
concentrations of 3M (red box represents crystallization conditions 1M). Crystals 
produced for (D) a control protein sample, (E) with charge stablized particles, and 
(F) with PEGylated nanoparticles. 
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4.3.2. Nanoparticle-polymer conjugates act as nucleating agents for 
lysozyme crystallization 
Microscope images of the crystals that form for samples without nanoparticles, with 
uncoated, and with PEG coated gold nanoparticles (Figure 4.2D-F)  illustrate the 
similarity in the size and number of crystals formed with aggregated nanoparticles and in 
the control sample.  The purple residue covering the bottom of the reservoir in image 2E 
are nanoparticle aggregates that sedimented out of solution due to their large size.  Other 
groups have reported that gold and silica nanoparticles in crystal growth media lead to 
changes in the nucleation of protein crystallization.
9,10
 However, the effects may be 
attributed to the aggregates formed from these nanomaterials, similar to other 
macroscopic materials with rough, irregular surfaces such as horse hair, bioglass, dust 
and seaweed which are known to have nucleation effects.
16
  
The sterically stabilized nanoparticles (Figure 4.2, right) have very different effects on 
protein crystallization.  By engineering the polymer – nanoparticle conjugates to remain 
disperse throughout the crystallization solution, nucleation effects can take place in a 
homogeneous fashion throughout the medium.  As a result of many more nucleation sites, 
more net crystals are formed and since the available protein gets used equally by all sites, 
the final crystal sizes are smaller. These features are clear indications that the sterically 
stabilized gold nanoparticles are able to nucleate the crystallization of lysozyme.   
We explored whether the nucleation effects in Figure 4.2 depended on the polymer 
surface coating; Figure 4.3 shows that not all sterically stabilized nanoparticles induced 
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crystal formation. Only longer polymer coatings (>5K) can produce higher quantities of 
smaller crystals in a shorter amount of time.  Polymer – nanoparticle conjugates prepared 
with a range of PEG molecular weights from 1K to 30K were evaluated; in each case, 
solutions were red once added to the crystal growth media indicating a preservation of the 
steric stabilization of the PEG coatings.  The shorter poly(ethylene) glycol, of 1,000 and 
2,000 molecular weight, formed nanoparticle conjugates with little effect on the 
crystallization process.  The resulting lysozyme crystals were similar in size, count and 
time to nucleation (Tnuc) as the control protein crystals (Table 4.1).  Larger molecular 
weight polymers (more than 5,000 molecular weight) lead to a consistent set of 
nucleation effects: smaller and more numerous crystals, and faster nucleation.  Clearly, 
once the polymer chain lengths are long enough the nanoparticle-polymer conjugates are 
able to induce nucleation of the proteins.  
Table 4.1. PEG MWt dependent lysozyme crystallizaiton nucleation 
effects. 
* AuNP_30K PEG crystals were too small to detect distinct edges. 
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Figure 4.3. PEG molecular weight dependence on lysozyme 
nuclation.
 
Molecular weight of the polymer surface coating affects the nucleation properties 
of the polymer – nanoparticle conjugates. Larger molecular weight PEG (A) 
decreases the crystal size, (B) increase the number of crystals produced and (C) 
decreases the time to nucleation. 
 119 
 
4.3.3. Ruling out the influence of free polymer on nanonucleant 
effects  
The interpretation of the data in Figure 4.3 is complicated by the possibility that free 
polymer, rather than surface associated polymer, is affecting protein crystallization.  
Poly(ethylene) glycol is also a known additive for protein crystallization which is thought 
to increase nucleation events through excluded volume effects.
17,18
  It is typically used in 
concentrations (e.g. 0.5-10 w/w%) significantly higher than the nanomolar concentration 
of nanoparticle-polymer conjugates.  Still, in nanoparticle suspensions there may be some 
level of unbound polymer in equilibrium with the surface associated material as well as 
excess left behind from the surface conjugation reaction.    
To evaluate the influence of any free polymer, we compared the nucleation properties of 
sterically stabilized samples with varying levels of purification.  Three rounds of spin-
filtration (100 MWCO) are usually sufficient to remove any unbound impurities from 
nanoparticle suspensions: for some samples an additional three rounds of centrifugation 
followed by redispersal was employed. The concentration of free PEG in solution was 
estimated based on the concentration of PEG within the supernatant determined via total 
carbon analyzer (see Chapter 3).  Figure 4.4A shows the free PEG concentration of 
20,000 molecular weight PEG at various times during the purification process. The 
original nanoparticle solution was prepared to contain 280 molar 20K PEG (0.6 w/w%); 
after spin filtration, the concentration of PEG not bound to a surface was ~28 molar 
(0.06 w/w%). Centrifugation further cleaned the sample and provided a 290 nmolar 
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(0.0001 w/w%) concentration of free PEG.   In this way, samples with sub-millimolar 
levels of free PEG could be produced and compared in their crystallization behavior. 
We found that the time to nucleation was not substantially impacted by the purification 
processes even though the amount of free polymer in the suspensions was varied by 
orders of magnitude.  For example, samples purified via spin filtration had average 
nucleation times of 3.6 ± 0.5 hours while more highly pure materials had similar 
nucleation times, 3.3 ± 0.3 hours.  While the removal of free PEG from solution didn’t 
alter the time to nucleation it did change the morphology of the crystals. The images in 
Figure 4.4B show the crystals formed in the presence of micromolar free PEG were 
elongated with a higher aspect ratio while those formed in the more purified sample were 
cuboidal.  The size scale of the crystals remained similar; each had an average width 
between 60 and 70 μm.   
We also investigated the impact of very small PEG concentrations alone on the 
nucleation of protein crystals; the existing literature generally only covered highly 
concentrated PEG suspensions.
18,19
  Lysozyme crystals were formed without 
nanoparticles but with 6000 molecular weight PEG at concentrations from 0 to 25 
molar.  Figure 4.4C shows the resulting protein crystals and shows that crystal 
elongation occurs with increasing polymer.  However, the crystal count and net volume 
remain the same, in these solutions.   
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Figure 4.4. Free PEG on protein crystallization. 
 
4.3.4. The surface polymer chain length affects the polymer 
conformation: from brush to mushroom 
The one variable that is central to the design of nanoparticle-polymer nucleants is the 
polymer chain length; very short polymers clearly do not show any ability to affect 
lysozyme crystallization process.  However, when surface bound polymers are larger than 
(A) The concentration of free 20KPEG in solution during cleaning steps 1 – 6; 
steps 1-3 were spin filtered samples using 100 MWCO filters at 4150 RPM for 15 
minutes, steps 4-6 were centrifugation at 11,500 RPM for 99 minutes.  (B) Time to 
nucleation and images of lysozyme crystals with AuNP_20KPEG after 
purifications steps 1-3 (AuNP, Long PEG) and after 1-6 (AuNP, Long PEG more 
purified). (C) Lysozyme crystallized in the presence of increasing concentrations of 
free PEG from 0 to 2.5x10 
-5
M.  
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5000 MWt they show increasingly greater effects on the crystallization process.  In order 
to understand this trend, we examined how the polymers at the nanoparticle interfaces 
changes in their surface coverage in Chapter 3.  Clearly, as chains became longer they 
were less densely populating the interfaces.  We hypothesized that this was because the 
larger polymers adopted mushroom conformations and needed more space per chain at 
the interface.  To verify this we examined quantitatively the hydrodynamic diameter of 
the various nanoparticle-polymer conjugates as a function of their molecular weight.   
Figure 4.5A shows that as the molecular weight of the PEG increases from 1K to 30K, so 
does the overall length of the polymer on a nanoparticle surface determined from the 
difference in hydrodynamic diameter (HD), and the core diameter (d).  However, this 
increase is not linear and appears to level off for longer polymer chains.  To place these 
results in context, we bracketed the experimental data between the maximum extension 
of poly(ethylene) glycol (green line) and the fully coiled polymer diameter for free 
polymer in solution (red line).  The former is defined as the length of a single monomer 
(0.35 nm) multiplied by the number of monomers per polymer (n).
20,21
  This is an 
unrealistic conformation as the polymer will exhibit secondary structure that could make 
it much more compact.  The coil dimension (Coil) was calculated using Equation 4.2.
22
  
Equation 4.1. Hydrodynamic diameter unbound polymer coil 
      {
    
     
}
 
 
 
Where, MW is the molecular weight, 𝜂 is the intrinsic viscosity, and NA is Avogadro’s 
number. The intrinsic viscosity is calculated using 𝜂 = K * MW^
α
; where K and α are 
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constants for a given polymer based on the solvent and temperature.  For PEG in water at 
room temperature K = 0.0224 mL mol
-0.73
 / g
1.73 and α = 0.73.23 We would expect that at 
an interface the polymers would be larger than this free coil diameter which requires 
ample interactions between all parts of a polymer chain.  
As is apparent in Figure 4.4, for all chain lengths the poly(ethylene) glycol length at the 
surface is in between the extreme extended limit and the free polymer coil.  The samples 
are most similar to the extended configuration when they are shorter as shown in panel B.  
Here the experimental polymer thickness is expressed as a percent of the extended length.  
For the 5 nm gold nanoparticle-polymer conjugates the percent extensions were: 59 ± 2% 
(1K); 54 ± 6% (2K); 47 ± 4% (5K); 48 ± 8% (10K); 32 ± 10% (20K); and 19 ± 0% 
(30K).  The same trend occurs for gold nanoparticles of 10, 15 and 20 nm diameter, 
except that for the larger particles the shorter PEG can be even more extended. 
Similar data has been seen for polymers attached to flat interfaces, as well as for other 
kinds of polymers attached to nanoparticles.
21,24,25
  Briefly, the shortest polymers will 
densely pack at interfaces to maximize their interchain interactions resulting in a “brush” 
conformation (Figure 4.4B inset).  As polymer chain length increases, intrachain 
interactions become more important and some coiling occurs resulting in a “mushroom” 
conformation for tethered (Figure 4.4B inset). Typically, the brush regime is 
distinguished by “an significant extension”, and Krueger et. al. classified polystyrene 
coatings on nanoparticles with extensions between 30 - 50% as “brushes”.22,26   For these 
polyethylene coatings it is clear that brush behavior is found for extensions between 50 
and 70% corresponding to polymer chain lengths below 5,000 molecular weight.   
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Figure 4.5 Evaluation of PEG based on length and extension 
 
4.3.5. Protein association with nanoparticle-polymer conjugates: 
chain length dependence 
One feature of how nanoparticle-polymer conjugates act in protein crystallization is the 
pronounced chain length dependence. As seen in Figure 4.3, shorter chains lead to no 
effect at all on crystallization while longer chains appear to optimize the nucleation. We 
reasoned that this trend could be explained by an increased protein association with 
nanoparticle-polymer conjugates. 
This hypothesis was based on the observation made in this group and other that short 
molecular weight polymers are densely packed at nanoparticle interfaces; they are 
Evaluation of the polymer coating based on (A) length and (B) percent extension (B).  
The length versus molecular weight for unbound polymer fully extended (green) or 
in a random coil (red) is compared to the thickness of the polymer bound to a 5 nm 
(red squares), 10 nm (green squares), 15 nm (blue squares) or 20 nm (purple 
squares). Binding to a surface causes the polymer to extend and the percent extension 
defines the conformation as either brush (extended) or mushroom (less extended). 
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extended in a brush-like conformation with high surface densities (see Chapter 3).
22,27
  
Consequently shorter polymers are preferred when nanoparticle core surfaces need to be 
very protected and inaccessible in solution.  In contrast, longer molecular weight 
polymers assume a more coiled, mushroom-like structure and thus have lower packing 
density at nanoparticle interfaces.  What results are fewer polymers protecting a core 
nanoparticle surface.  Additionally, there is a more irregular and more porous polymer 
layer presenting itself to the aqueous solution.  We reasoned that such a surface would 
have more assocation with proteins.  
Lysozyme association with nanoparticle-polymer conjugates was best measured using 
equilibrium dialysis experiments.  In these studies, any protein not bound to a particle can 
migrate through a dialysis membrane while protein associated with the polymer – 
nanoparticle conjugate cannot.  Figure 4.5 (black line) shows that only 30% of a control 
sample of lysozyme under these conditions was retained within the membrane after six 
days.  When lysozyme was exposed to citrate stabilized gold nanoparticles, a nanoparticle 
known to strongly associate with lysozyme, 58% of the protein was retained inside of the 
filter.
28
  For polymer – nanoparticle conjugates the amount of protein retained varied 
consistently with the molecular weight of the PEG coating (Figure 4.5).  Conjugates 
made from the shortest molecular weight polymers (1K and 2K) showed relatively small 
retention of proteins inside of the filter, 45 ± 5% and 55 ± 9% respectively.  Once 
coatings were longer than 5000 molecular weight, however, the retention of lysozyme by 
the nanoparticle increased smoothly: 60 ± 4% (5K), 69 ± 6% (10K), 72 ± 3% (20K), and 
76 ± 1% (30K).  
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Typically, biomolecule associations can be measured by analytical ultracentrifugation 
(AUC), where changes in the sedimentation properties of a nanoparticle sample in a 
protein rich environment indicate that an interaction has occurred.
29
 Given our experience 
with AUC, we initially turned to this tool for probing the association of free proteins with 
nanoparticles.  However, we could find no significant change in the sedimentation 
coefficients of particles exposed to lysozyme.  It may be that the shearing force on the 
sedimenting particles was enough to strip weakly associating proteins from the conjguate 
surfaces.  
The strength of the interaction between the protein lysozyme and the nanoparticle-
polymer surface is not easily measured.  We can infer, based on our AUC and 
equilibrium dialysis data, that it is relatively weak interaction.  Our crystallization data 
also supports this inference.  Strong nanoparticle – protein associations have been shown 
to disrupt a protein’s structure.30  Proteins in partially unfolded or in super folded 
conformations would not be appropriate nucleation sites for addition proteins, and in fact 
would be likely to reduce nucleation events, rather than to enhance them as we observe.  
Additionally, as will be presented in Chapter 6, the diffraction from crystals formed in the 
presence of nanoparticles matches the native lysozyme structure indicating little 
disruption to the protein structure.  
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Figure 4.6. Nanoparticle – protein association. 
 
4.3.6.  Effect of nanoparticle-polymer conjugates on protein 
nucleation 
One observation about the mechanism for the nanoparticle-polymer conjugate effects on 
protein crystallization is that there is a concentration dependent decrease on the time to 
nucleation even in protein concentrations below the supersolubility region. The Tnuc for 
lysozyme without a nucleant is highly concentration dependent. Figure 4.6A shows that 
Lysozyme association, as determined from equilibrium dialysis, increases with 
PEG molecular weight. All samples containing nanoparticle retained more of the 
protein than the control sample (black line), while only samples with polymer 
molecular weight coatings >5K exceeded the retention for bare nanoparticles (red 
dashed line), which are known to associate with lysozyme. Error bars are the 
standard deviation from n=3. 
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protein concentrations greater than 4 mg/mL easily overcome the free energy barriers for 
crystallization and have a similar Tnuc as samples with a nanoparticle nucleant present.  
However, by reducing the initial protein concentration the control sample shows a 
significant increase in Tnuc.  Adding short molecular weight polymer – nanoparticle 
conjugates result in the same concentration dependent Tnuc as the control sample for all 
concentrations. In contrast, the large molecular weight polymer – nanoparticle conjugates 
nucleate crystal formation at a reduced Tnuc regardless of the initial protein concentration.  
This results in crystal formations that are three times faster at 3.5 mg/mL and seven times 
faster at 3.0 mg/mL.  Figure 4.6B, shows at 3.5 mg/mL, when there are 10 million times 
more proteins than nanoparticles, there is still a 2.4 fold decrease in the time to 
nucleation.  As the concentration of nanoparticles is increased for a particular protein 
concentration, nucleation is faster but eventually reaches a plateau corresponding to a 
five fold reduction in nucleation time. From these results we can conclude that large 
molecular weight polymer – nanoparticle conjugates are heterogeneous nucleants.  They 
are able to promote nucleation even when protein concentrations are well below the 
supersolubility limit.  
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Figure 4.7. Concentration dependent changes in Tnuc. 
 
In addition, phase diagrams with and without nanoparticle nucleants (Figure 4.7) show 
that nanoparticles expand supersolubility for lysozyme which promotes the formation of 
crystals while reducing precipitation. Small volume batch method crystallization 
conditions with lysozyme concentrations from 5 to 60 mg/mL and ionic strength 
solutions from 0.5 to 4.0 M with long polymer – nanoparticle conjugates have more 
“hits” (conditions that form crystals) and a decrease in conditions that produce protein 
aggregates. Protein crystals are found in 43% of the conditions with protein alone and 
58% with nanoparticle additives.  The experiment was repeated (not shown) and found 
that the same expansion of protein solubility and similar increase in conditions had 
crystal hits: 40% and 56% without and with nanoparticles, respectively.  
(A) Lysozyme concentration and (B) nanoparticle per protein concentration effects 
on the time to nucleation (Tnuc) for lysozyme control (black squares), short polymer 
– nanoparticle conjugates (blue circles) and long polymer – nanoparticle conjugates 
(red squares). Nanoparticle concentration dependent curve was run at the 3.5 
mg/mL initial lysozyme concentration. 
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The consequences of this observation are significant as it suggests the use of 
nanoparticle-polymer conjugates as additives to improve high-throughput protein 
crystallization.  Current methods for high throughput screening subject a protein to a 
multitude of conditions, which differ in solvent, buffer composition, pH, buffer strength, 
ionic strength and/or additive concentrations.  The object is to determine the best set of 
conditions to produce crystals.  However, these screening methods suffer from a low 
success rate, time consuming crystal formation, and tedious sample evaluation to detect 
crystals.
3
  By including polymer-nanoparticle conjugates there is a greater probability that 
crystals will form during the screen.  Also, crystals are more easily visualized due to their 
strong color.  
 
Figure 4.8. Lysozyme phase diagrams. 
 
Lysozyme phase diagrams were generated for protein concentrations from 5 to 60 
mg/mL in ionic strength solutions containing NaCl from 0.5 to 4.0 M. Blue squares 
represent clear conditions, red squares are conditions that formed precipitates and 
the black diamonds are conditions that produced crystals. Supersolubility curves 
are show for each sample; (A) without nanoparticles and (B) with nanoparticles. 
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As an example, Figure 4.8 shows that nanoparticle-polymer conjugates expanded the 
number of crystal forming conditions and also decreased the precipitate formation for 
lysozyme. Two sets of 96 crystal screening solutions; PEG Suite (Qiagen) and Index 
Screen (Hampton Research) were used to prepare 192 unique conditions for three 
samples: a control protein stock solution, and the same stock solution with either 1 nM or 
10nM nanoparticle-polymer conjugate (gold 10nm, 20000 MWt PEG). At either 
concentration the nanoparticle-polymer conjugates increased the number of protein 
crystal forming conditions and decreased the occurrence of precipitates (Figure 4.8A).  
The control sample crystallized in 63 of the conditions, while the low nucleant 
concentration yielded 72 crystal forming conditions and the higher nanoparticle 
concentration had crystals form in 70 cases.  In this case, the additive didn’t prevent the 
formation of precipitates at 1 nM, however they slightly reduced precipitate formation at 
the higher concentration.  There were 38 precipitating solutions for the control and low 
concentration samples and 34 for the higher nucleant concentration.  
Nanoparticles behave ideally for use in current screening strategies, they are easy to 
introduce and facilitating crystal formation without disruption to the set of conditions that 
were favorable for the control sample.  A measure of this is the number of unique 
crystallization conditions; cases where crystals formed for either the control or the 
samples containing nanoparticles but not for both.  Figure 4.8B shows 4 uniquely 
crystallizing conditions for the control, and 26 with nanoparticles. Meaning screens with 
nanoparticles enhance crystallization without detraction from the native sample. 
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Nanoparticle nucleants were easily incorporated into high throughput strategies and 
improved the crystallization process.  However, lysozyme is a protein that is already 
straightforward to crystallize.  To evaluate the generality of the results, a set of five 
additional proteins were evaluated to determine if nanoparticle-polymer conjugates could 
be advantageous as nucleants for harder to crystallize proteins.  
 
Figure 4.9. High throughput crystallization of lysozyme. 
 
4.3.7. Nanoparticle-polymer conjugates nucleate the crystallization of 
diverse proteins 
The five additional proteins evaluated were ferritin, human serum albumin (HSA), lipase 
B, xylanase, and glucose isomerase; Table 4.2 shows the characteristics of all the proteins 
used to evaluate the use of nanoparticle nucleants in high throughput strategies.  The net 
High throughput crystallization of lysozyme count of the conditions that (A) form 
crystals or precipitate without nanoparticles (black bars), with 1 nM polymer – 
nanoparticle conjugates (pink bars), and with 10 nM polymer – nanoparticle 
conjugates (red bars). (B) Unique conditions are those that form crystals or 
precipitates either without nanoparticles (black bars) or with nanoparticles (red 
bars), but not in both cases. 
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surface charge for each protein will be different because their isoelectric points range 
from 3.0 to 11.0.  The protein dimensions range from 12.5 x 12.5 nm for ferritin to 4.5 x 
3 nm for lysozyme.  For size comparison the core gold nanoparticle are on the order of 10 
nm (11.7 nm) and the average 20K PEG thickness is ~30 nm, resulting in a conjugate 
diameter of ~70nm; Figure 4.10 represents pictorially the relative sizes of the proteins to 
the core particle.  
Table 4.2. Protein characteristics. 
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Figure 4.10. Relative sizes of the proteins and the core nanoparticle, 
d=10 nm gold. 
 
Protein structures obtained from the protein data bank and displayed for their size 
relative to the 10nm gold nanoparticles. Sizes of the proteins range from 12.5 nm 
for ferritin to 3x3x4 nm for lysozyme.  
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Figure 4.11. High throughput crystallization screens of ferritin, human 
serum albumin (HSA), lipase B, xylanase, glucose isomerase and 
lysozyme. 
 
Figure 4.10A&B show graphically the information in Table 4.3; polymer – nanoparticle 
nucleants are successful at increasing the number of crystal forming conditions, or ‘hits’, 
for all the proteins evaluated. Ferritin crystals formed in only 5 solutions for the control 
sample as opposed to 12 and 19 hits for a relative change of 140% and 280% over the 
High throughput crystallization screen results for ferritin, human serum albumin 
(HSA), lipase B, xylanase, glucose isomerase and lysozyme. Counts of (A) the total 
number of conditions that form crystals and (B) their change relative to the control. 
(C) Unique crystals forming conditions* for the control samples without 
nanoparticles (black bars), with 1 nM polymer – nanoparticle conjugates (pink 
bars), and with 10 nM polymer – nanoparticle conjugates (red bars). Dashed line 
was added at 100% as a guide to the eye. 
*Unique conditions are those that form crystals either without nanoparticles (black 
bars) or with nanoparticles (red bars), but not in both cases.  
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control with the 1 nM and 10 nM nanoparticle additives, respectively.  Human serum 
albumin had only one macroscopic crystals form and it occurred in a condition prepared 
with the high concentration of nucleant (100% relative change). Lipase B had a slightly 
higher number of control crystal hits, forming crystals in 6 solutions. For samples with a 
1 nM addition of nanoparticle nucleants the number of crystal forming conditions 
increased from 6 to 12, (100%) while the high concentration of nucleants only had 5 (-
17%) conditions that formed crystals. The xylanase control sample had 2 crystal hits, 
while the nucleant samples induced 1 and 5 hits for a -50% and 150% relative change for 
the 1nM and 10nM concentrations. Glucose isomerase, like lysozyme, has a high success 
rate of crystallization (43, 22% of all conditions tested) for the control sample. However, 
glucose isomerase had a more significant relative increase, 26% (11 more conditions) 
with the low concentration and 37% (16) with the higher nanoparticle concentration.  
Unique crystal forming conditions have crystals form only with or without nanoparticles, 
but not for both. A total of only six unique conditions formed without nanoparticles for 
all of the samples, in contrast with  74 unique conditions found with nanoparticle and 
every protein has at least one (Figure 4.10C). Nanoparticle nucleants increase the crystal 
hit rate by facilitating the formation of crystals in conditions that do not work for the 
native protein control sample. Ferritin, glucose isomerase, and lysozyme had 15, 22, and 
23 unique conditions with nanoparticles which account for 48%, 19% and 16% of all 
their crystal forming conditions, respectively.  The proteins that had fewer crystals hits 
also had fewer unique conditions with nanoparticles, but these conditions account for a 
greater percentage of crystallizing conditions, i.e., human serum albumin has 1 unique 
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condition, which is 100% of crystal forming conditions, lipase B has 9 which are 53% 
and xylanase has 4 for 67%.  Nanoparticle nucleants are able to form crystals in unique 
conditions by expanding the phase space and allowing crystallization in metastable 
regions, thus increasing the success of a crystallization screen.  
Table 4.3. High throughput crystallization results for multiple proteins.  
 
 
We also evaluated pre-crystalline materials such as microcrystals, blobs or fibrils in the 
screens with and without the nanonucleants.  Such products can indicate a region where 
favorable protein interactions are possible and therefore the set of conditions could 
possibly be optimized to yield a viable crystal. Distinguishing between precipitates and 
microcrystals can be difficult. For consistency, we considered two main properties to 
differentiate the two: reflectivity and placement in the well.  As seen in Figure 4.11A the 
precipitates tend to be more buoyant, less reflective, and not isolated in defined sections 
of the well. Microcrystals, as shown in Figure 4.11B, are typically more reflective and 
 (-) is without nanoparticles (+) is with 1 nM nanoparticles, (++) is 
with 10 nM nanoparticles 
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dense; which allow them to settle to the bottom of the well, usually in a uniform fashion. 
Determining the cutoff from microcrystal to crystals was done through visible 
identification of facets using a microscope at 10 X magnifications or below, 
microcrystals are too small to make out individual faces at these magnifications. 
 
Figure 4.12. Products of crystallization. 
 
Figure 4.12 shows that the nanoparticle-polymer conjugates also decrease the number of 
conditions that form unfavorable precipitates and increase the total crystallization hits 
including pre-crystalline materials.  Human serum albumin and lipase B have similar 
nucleant concentration dependent decreases in the number of conditions that form 
precipitates and increases in total hit counts.  Ferritin and lysozyme behave similarly, 
neither protein sample decreases in the precipitate forming conditions with the low 
concentration of nanoparticle nucleants, yet they both show a greater total hit count at 
that nucleant concentration.  Glucose isomerase has a significant decrease in precipitation 
with the lower concentration nanoparticles, but many of the conditions that precipitated 
with the higher concentration of nanoparticles formed pre-crystalline microcrystals with 
Images of crystallization products: precipitate (A), microcrystals (B), crystals (C).  
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the lower concentration, signifying how closely related these conditions tend to be. 
Xylanase only had one precipitate forming condition and that was for the control sample, 
with the addition of nanoparticles that condition did not form precipitates.  For lysozyme 
the total hit count and the number of crystals hits are the same because lysozyme only 
formed crystals or precipitates. 
 
Figure 4.13. High-throughput results. 
 
Another observation during the crystallization of the high crystal hit rate samples 
(ferritin, glucose isomerase and lysozyme) was the increase in crystal quantity with 
increased nanoparticle-polymer conjugate concentration. The time it takes to nucleate 
Crystallization wells typically form either precipitates, microcrystals or crystals. 
(A) Number of conditions that form precipitates and (B) total “hits” including 
crystals and precrystalline materials increase for all protein samples. The change 
relative to the for (C) precipitate formation and (D) total hits.  Black bars are 
control proteins without nanoparticles, pink with 1 nM nanoparticles, and red bars 
are for 10 nM nanoparticles; dashed lines added at 100% change as a guide to the 
eye. 
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crystal formation affects the quantity and size of produced crystal sample; a faster 
nucleation results in more abundant and smaller crystals.  Many of the screened 
conditions for ferritin, glucose isomerase and lysozyme formed crystals, these conditions 
also tended to have crystal count increases as the nanoparticle concentration was raised 
from 1 nM to 10 nM.  For the condition shown, ferritin crystal quantity increases from 
zero without nanoparticles, to 8 with 1nM AuNP and to 26 with 10 nM AuNP (Figure 
4.13A). Glucose isomerase crystals are shown in Figure 4.13B and form in quantities of 
one, four and ten with 0, 1 and 10 nM AuNP additives respectively. For the condition 
shown in Figure 4.13C lysozyme crystals counts are zero, two and three with increasing 
nanoparticle concentrations.  
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Figure 4.14. Concentration effects of nanoparticles. 
 
Concentration effects of nanoparticles on crystal counts for (A) ferritin, (B) glucose 
isomerase and (C) lysozyme.  (D) The increase in nanoparticle concentration 
correlated with an increase in the number of crystals that formed; black bars are 
without nanoparticles, pink with 1 nM nanoparticles, and red bars are for 10 nM 
nanoparticles. 
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4.4. CONCLUSION 
Nanoparticle-polymer conjugates can be designed to nucleate protein crystallization.  
Large molecular weight PEG assume a mushroom-like coiled conformation creating 
surfaces that allow protein association; this association promotes nucleation in a manner 
similar to heterogeneous nucleation. These sterically stabilized nanoparticle-polymer 
conjugates remain non-aggregating in crystal growth media.  They produce more protein 
crystals in a shorter amount of time than protein alone; this effect is due to the 
nanoparticle-polymer conjugate as opposed to free polymer or free nanoparticle.  
Polymer – nanoparticle conjugates could be easily incorporated into high throughput 
crystallization screens.  In this setting, they increased the occurrence of crystal “hits” as 
well as unique crystal forming conditions.  They also decreased the prevalence of protein 
precipitation in many different kinds of proteins.  Nanoparticle-polymer conjugates can 
have significant effects on protein crystallization, and offer as nucleants many properties 
useful for improving high throughput crystallization strategies 
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Chapter 5 
MESOSCOPIC BIOTEMPLATES FORMATION OF 
COMPOSTITE (NANOPARTICLE-PROTEIN) 
CRYSTALS 
 
In the last Chapter we illustrated how nanoparticle – protein associations can promote the 
nucleation of protein crystals.  Here, we consider the properties of the resulting crystals.  
Nanoparticle-polymer conjugates are examples of nucleating agents that become 
internalized into the growing crystal.  What results are composite nanoparticle-protein 
*Work performed within this chapter is the collaborative efforts of me and members of 
the Colvin lab, Hafner lab and Shamoo lab. Courtney Payne (Hafner lab) provided all of 
the PEGylated shaped gold nanoparticles, Dr. Huiguang Zhu (Colvin lab) provided all 
of the PEGylated quantum dots and iron oxide materials, Dr. Carolina Avendano 
(Colvin lab) ran and processed all SQUID data, Kasia Walkiewicz (Shamoo lab) 
provided training for crystallization techniques. In addition, I had help from many 
Colvin lab interns including: Montoya Savala (Preliminary work with quantum dots), 
Ajoke Williams (UV-vis spectroscopy), Raymond Verm (UV-vis spectroscopy), 
Michael Lillierose (nanoparticle sample prep and characterization), and Naushaba Ali 
(nanoparticle sample prep and characterization). 
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materials with relatively high concentrations of nanoparticles.  One interesting finding is 
the sheer range of nanoparticles that can be incorporated at high concentrations into 
protein crystals.  Gold nanoparticles up to 50 nm diameter; gold prisms and rods; iron 
oxide nanoparticles and quantum dots all could be incorporated.  The only critical design 
feature was the polymer surface coating: they had to provide steric stabilization in the 
crystal growth medium and long enough poly(ethylene) glycol chains to ensure that the 
polymers were close to a mushroom-like conformation. The properties of the resulting 
nanoparticle-polymer composites are reflective of the type of nanoparticle that is 
incorporated.  For most examples, the properties of the composite are similar to that of 
the individual nanoparticles. The one exception was found for iron oxide nanoparticles 
which were apparently non-magnetic at low temperatures in these crystals.    
5.1. INTRODUCTION 
The collection of nanoparticles into solid phase hosts – either randomly arranged or 
ordered – has great potential value in areas as diverse as catalysis and medicine.1-7  In 
such structures the individual properties of the nanoparticles can simply be multiplied by 
their collection into a larger material; alternatively, nanoparticle-nanoparticle interactions 
can give rise to new optical and magnetic phenomena.  Supraparamagnetic particles, for 
example, if they are within several of their diameters from each other can align their 
magnetic dipoles giving rise to large, permanent magnetization.
8,9
 Optically active 
resonances in metals can lead to smaller energy excitations.
10-12
  Such collective 
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properties provide an additional level of tunability for nanoscale materials and in some 
cases entirely new kinds of behavior.   
A challenge for the material chemist is the formation of these nanoparticle collections in 
three-dimensional and optically transparent substrates.  Costly lithography processes can 
provide only a two dimensional pattern; for three dimensions other strategies based on 
chemical assembly are more practical.  Natural systems provide excellent examples of the 
assembly of organic and inorganic materials into bulk composite materials.  
Biomolecules can have functions that interact with inorganic components, and also 
present moieties that help define a larger hierarchical ordering for a macroscopic 
structure.
13
  Bone is perhaps the best example of this.
14
   
These observations have inspired chemists to leverage the association of biomolecules to 
collect and in some cases even order nanoparticles in three dimensional composite 
materials.  One of the first examples was the use of two-dimentional arrays of s-layer 
proteins to template nanoparticle binding to surfaces.
15
 Other methods have used 
nanoparticles modified with peptides, proteins, RNA, or DNA which form arrays that can 
incorporate the bionanoconjugates.
16-20
 Protein and virus crystals have also been used to 
define arrays of metal nanostructures.
6,21-24
  In some examples, a nanoparticle is first 
grown inside of a protein or virus capsid which his subsequently crystallized; in other 
cases, the nanoparticles are formed after the crystallization process by the infusion of 
precursor salts and subsequent reactions to form solid state materials.
6,22-24
 These 
approaches allow only materials to be formed within the pores and cavities of the 
biomolecule, a constraint which necessarily limits the size and composition of particles.   
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In this Chapter, we show that through the design of the appropriate surface, 
nanomaterials can be driven to incorporate into three dimensional protein crystals.  
Central for this incorporation is the use of surface attached polymers at nanoparticle 
interfaces.  These coatings both provide steric stabilization to the nanoparticles during the 
crystal growth process, as well as ensure weak interactions with proteins. When proteins 
subsequently begin to crystallize, nanoparticles are incorporated into the growing crystal.  
What results is a very concentrated protein-nanoparticle crystal that contains a highly 
organized protein lattice with inorganic nanoparticles evenly distributed throughout the 
structure.   The incorporation process can be applied to wide range of nanoparticle 
compositions (e.g. quantum dots, magnetic oxides, nobel metals) and even shapes.  Most 
examples of nanoparticle-protein composites exhibit optical, fluorescent and magnetic 
properties reflective of the incorporated nanomaterials.  In the case of nanorods, however, 
the protein crystallization process serves to align the rods along one axis leading to strong 
polarization in the resonant plasmon modes.   
5.2. RESULTS AND DISCUSSION 
5.2.1. The dynamic incorporation of nanoparticles into protein 
crystals 
As discussed in Chapter 4, nanoparticle-polymer conjugates can be designed to weakly 
associate with many proteins.  The most critical parameter to control is the length of the 
surface attached polymer chain.  Large molecular weight poly(ethylene glycol) (PEG) 
coatings allow for the weak association of proteins with the nanoparticle-polymer 
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conjugates, and consequently the rapid nucleation of protein crystals (Chapter 4, Figures 
4.5 and 4.6).   By way of review lysozyme crystallization solutions are shown in the 
Figure 5.1(A-H) for four samples: the control, without any nanoparticles, with the 
addition of citrate coated gold nanoparticles (AuNP) and two samples containing polymer 
– nanoparticle conjugates (AuNP_PEG); a short molecular weight polymer and a longer.  
The lysozyme control sample, image 1A, is a clear solution.  After 24 hours at 10 °C 
clear crystals have formed on the cuvette walls and deposited on the floor of the cuvette 
from the solution.  The middle case, a non-sterically stabilized gold nanocrystal, becomes 
aggregated in solution – turning purple and resulting in no change to the crystal number 
or size.  However, nanoparticle-polymer conjugates remained dispersed and the sample 
containing the longer polymer had rapid formation of many red protein crystals.   
A feature not discussed in Chapter 4 is the notable color of the crystals for the rapidly 
nucleating crystals.  As is apparent in Figure 5.1, nanoparticle-polymer conjugates that 
promote nucleation also result in the formation of crystals with a distinct red color.  Also 
notable is that the color of the gold nanoparticle solution becomes less pronounced.  We 
reasoned that the gold nanoparticles must incorporate into the growing protein crystals.  
Over time this depletes the solution of gold nanoparticles as the red crystallites transfer 
from the solution phase into the growing crystals (Figure 5.1H). 
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Figure 5.1 Lysozyme crystallization images. 
 
We used absorbance spectroscopy to measure the change in the solution concentration 
versus time.  The absorbance at 301 nm (Figure 5.2A) and 523 nm (Figure 5.2B) were 
used to determine the change in lysozyme concentrations (Figure 5.2C&D) 
spectroscopically for four crystallization samples: a control sample, an ionically 
(A,E,I) Lysozyme control sample, (B,F,J) with citrate coated gold nanoparticles, 
(C,G,K) AuNP_1KPEG coated gold nanoparticles and (D,H,L) AuNP_5KPEG 
coated gold nanoparticles (A-D) at time 0 hours, (E-H) after 24 hours at 10 °C and 
(I-L) the resulting microscope images a 4X magnification. 
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stabilized gold nanoparticle (5 nM), and two nanoparticle-polymer conjugates; a short 
2000 molecular weight coated sample and a long 20,000 molecular weight coated sample. 
Two concentrations of nanoparticle polymer conjugate were analyzed 5 nM and 10 nM.  
The black curve (only at 301 nm) shows the control sample for which only protein is 
present; because nucleation is not rapid, its concentration changes only slightly in the first 
several days.  After correcting for the nanoparticle absorbance contribution in the UV 
region of spectrum lysozyme curves could be determined for all the samples. The 
ionically stabilized nanoparticle rapidly aggregates and is removed from solution, 
resulting in a drastic and rapid drop in the absorption due to sedimentation of the gold 
nanoparticle aggregates (Figure 5.2B).  Some protein is also removed as it is known to 
surface associate with the charged gold surface (Chapter 4, section 4.3.4). 
The nanoparticle-polymer conjugates had different behavior in the crystallization growth 
media than these two controls.  Over sixty hours, the sample with the shortest polymer 
chain (blue) had little change in either the protein or nanoparticle-polymer concentration, 
regardless of loading.  This is consistent with the observations noted in Chapter 4 which 
found these particles had little impact on protein crystallization. In contrast, the 
nanoparticle-polymer conjugate with the longer 20,000 molecular weight polymer 
coating had a steady decrease in both the protein and the nanoparticle concentration.  
Each component was removed from the solution at a constant rate, an observation 
consistent with a co-crystallization of both species.  The depletion of the lower 
concentration of nanomaterials was complete at 38 hours, while the protein continued to 
decrease.  In this sample, the nanoparticle-conjugate was used up in the early stages of 
the crystallization process. 
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Figure 5.2 Change in protein and nanoparticle 
concentrations
 
 
The raw absorbance at (A) 301 nm and at (B) 523 nm over time, used to determine 
lysozyme concentrations during crystallization for a control sample (black), citrate 
coated gold nanoparticles (AuNP, purple), 2K PEG-SH coated gold nanoparticles 
(AunP 2KPEG, blue) and 20K PEG-SH coated gold nanoparticles (AuNP 
20KPEG,red). After correcting the absorbance at 301 nm for the contribution from 
the gold nanoparticle in solution it was show that the lysozyme concentration 
changes most over time, for samples with AuNP 20KPEG.  Lysozyme 
concentration change for (C) samples that had 5nM or (D) 10 nM gold 
nanoparticles added. 
 153 
 
5.2.2. The relative incorporation of nanoparticles into protein 
crystals: distribution coefficients 
Distribution coefficients (KD) are used to evaluate the relative ratios of incorporation of 
two materials.  KD is defined based the ratio of the molar concentrations of nanoparticles 
(AuNP) and lysozyme (protein) in the crystal (x) and the initial solution (0).     
Equation 5.1. Distribution coefficient. 
    
       
          
       
          
 
KD values are used to determine preferential incorporation of one material over the other; 
a value of 1 means the materials crystallize equally, resulting in the same ratio of protein 
to nanoparticles in the crystals as in the initial solution.  Values greater than 1 occur when 
the nanoparticles are incorporated into the crystal at a higher yield and values less than 1 
show that the protein was preferentially crystallizing, without the nanoparticles.  Studies 
of hen egg-white lysozyme crystallization with turkey egg-white lysozyme found 
distribution coefficients near one, illustrative of the fact that these two proteins are 
chemically highly similar.
25
  In this work the concentration of each species in solution 
was found from the initial absorbance spectrum, while the concentration in the crystal 
was deduced from the difference between the final solution concentrations and the 
starting concentrations. 
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Figure 5.3 shows the KD for nanoparticle – protein composite crystals formed over a wide 
range of conditions and polymer chain lengths.  Figure 5.3A shows a concentration 
dependent decrease in the distribution coefficients.  As the concentration of nanoparticle-
polymer conjugate formed with longer PEG increased from 0.004 to 40 nM ([lysozyme]= 
0.25 ± 0.01 mM) the KD values went from 2 to ~1.  The high KD values at the low 
concentrations show that the nanomaterials were preferentially incorporating into the 
crystals, presumably because at lower concentrations the only nucleation sites were at the 
nanoparticles. However, as the nanoparticle concentration increased the protein and 
nanoparticle incorporation becomes uniform and resulted in KD values near 1. While 
there are variations in the uptake of nanoparticles over the range of conditions, the 
consistency of distribution coefficient values near 1 suggests that the nucleation object – 
which is likely a lysozyme associated nanoparticle - is similar thermodynamically to that 
for free lysozyme.  
The nanoparticle to protein ratio also affected the percent yield for protein crystallization; 
the control sample had 46% of the lysozyme formed into crystals after 3.5 days.  
Increasing the nanoparticle-polymer conjugate concentration produced crystallization 
yields greater than 80%.  Also, for nanoparticle (5.0 ± 1.0 nM) and protein (0.28 ± 0.02 
mM) concentrations an increase in KD as well as the crystallization yields was seen with 
increased molecular weight (Figure 5.3B&D).  The two shortest molecular weight coated 
particles have low KD values of near zero as they have no impact on crystallization.  As 
the chain length of the polymer around the nanoparticle conjugate increased, the 
distribution coefficients approached 1.  We measured KD values of 1.9, 1.5, 1.5 and 0.8 
for 5K, 10K, 20K, and 30K PEG chain lengths.  
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A closer inspection of the dependence of both the distribution coefficient and 
crystallization on polymer chain length revealed the crystallization yield as well as the 
distribution coefficient are sensitive to the total volume occupied by nanoparticle-
polymer conjugates.  The largest (30,000 MWt) polymer-nanoparticle conjugates occupy 
100 times more space in the crystal per particle than the smallest nucleating (5000 MWt) 
polymer-nanoparticle conjugates.  For the same concentration, the more compact 5,000 
MWt conjugates coating had a greater incorporation as compared to the much larger 
30,000 MWt polymer-nanoparticle conjugate, but a minimal impact on the crystallization 
yield.  Lower concentration of the larger nanoparticle-polymer conjugates also showed 
the same set of results, a significantly higher KD values with no increase in crystallization 
yield.  For these larger conjugates, an increased crystallization yield was only observed at 
relatively high concentrations of nanoparticle conjugates.  This suggests that the net 
volume of the crystal occupied by the nanoparticle-polymer conjugates changes with 
polymer coating and smaller coated materials may have a higher loading capacity in the 
crystal.   
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Figure 5.3 Distribution and percent yield graphs 
 
The distribution coefficients (top row) and percent yields (bottom row) for 
polymer-nanoparticle conjugates in protein crystals. Changes based on (A&C) 
increases in the AuNP 20KPEG nanoparticle concentration and (B&D) the polymer 
coating’s molecular weight (B&D).  Black lines are the percent yield for a control 
crystal sample. 
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5.2.3. The incorporation of nanoparticles into protein crystals is a 
general phenomenon that depends solely on the surface polymer 
interface 
All polymer–nanoparticle conjugates with PEG coatings that have an extension less 50% 
of the total hydrodynamic diameter of the coiled free polymer in solution are 
incorporated into composite crystals (See Chapter 4.3.4). Figure 5.4 shows images of the 
protein crystals produced using polymer–nanoparticle conjugates with AuNP from 5 to 
20 nm and PEG coatings from 1K – 30K. The images outlined in blue represent visibly 
clear crystals and those outlined in red are crystals that appeared red.  Every sample with 
a blue box has a corresponding polymer extension > 50%. This leads to Scheme 1A, 
showing that short molecular weight polymers which extended >50%, prevent the 
binding of protein on the surface and form clear protein crystals. Whereas all of the long 
molecular weight coatings with extensions <50% incorporated and formed protein – 
nanoparticle composite crystals, which are red. These incorporations are driven by the 
association of protein with interface of the nanoparticle-polymer conjugates as shown in 
Scheme 1B.  The proteins are able to associate with the polymer layer; this association, 
which is weak, raises the local concentration of protein around the conjguates and 
promotes the formation of a crystal nucleus.  
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Figure 5.4. PEG chainlength dependence 
images
 
 
 
 
 
 
Incorporation of nanoparticles from 5 nm – 20 nm with PEG coatings from 1K to 
30K shows a dependence on the polymer extension at the nanoparticle surface for 
all sizes of gold.  
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Nanoparticle-polymer conjugates formed from poly(ethylene glycol) larger than 5000 
molecular weight are incorporated into protein crystals regardless of their diameter, shape 
or core composition. Figure 5.4 shows gold nanoparticles with core diameters from 5 to 
50 nm coated with 20,000 molecular weight poly(ethylene) glycol.  All samples yielded 
red-colored crystals.  Moreover, other shapes of gold nanomaterials: cuboidal, 
bipyramidal, rods, and high aspect ratio rods, when coated with the same polymer also 
incorporated (Figure 5.6).  Furthermore, nanomaterials composed of silver, iron oxide, 
Scheme 5.1 PEG MWt and crystallization 
Short molecular weight PEG prevents incorporation long molecular weight PEG 
promotes protein association and leads to the formation of composite crystals. 
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cerium oxide and semiconductor materials, when coated with the 20K PEG were 
incorporated (Figure 5.7).   Therefore, the protein association that drives the formation of 
composite crystals does not rely on surface charge for electrostatic interactions, or sulfur 
– gold bonding. Instead the conformation and structure of the polymer coating defines the 
protein association, and subsequent promotion of nucleation and nanoparticle 
incorporation.   
 
Figure 5.5. Incorporation of nanoparticles based on size. 
 
Incorporation of nanoparticles from 5 nm – 50 nm with PEG coatings of 10K. TEM 
images of the core gold nanoparticles. All scale bars are 50 nm. Microscope images 
of the crystals with incorporated nanomaterial. 
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Figure 5.6. Incorporaiton of shape gold nanoparticles. 
 
 
Figure 5.7. Incorporation of other core compostitions. 
 
Composite crystals formed with 20K PEG coated (A) iron oxide, (B) cerium oxide, 
(C) CdSe/CdZnS quantum dots. 
Top rows: Sketches of the shapes of the nanoparticles determined from the TEM 
image of the nanoparticles. Bottom row: Images of the composite crystals formed 
through the incorporation of shaped gold nanoparticles: (A,E) cubes, (B,F) 
bipyramids, (C,G) rods and (D,H) high aspect ratio rods all with 20K PEG 
coatings.  
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5.2.4. Nanoparticle-protein composites have optical properties 
similar to that of isolated nanoparticles. 
Composite crystals retain the size and shape dependent optical absorbent properties of the 
incorporated nanomaterials.  Absorbance in the visible region of the light spectrum for 
gold nanoparticles produce the characteristic deep red to purple solutions, which vary 
depending on size and shape of the particles.  Spectral shift in absorbance of gold 
nanomaterials can yield information about stability, conformation and in our case, 
distance between particles.  Figure 5.8 shows the comparison of the optical absorbance of 
dried composite crystals formed using 10 nm, 15 nm and 20 nm spherical gold 
nanoparticle-polymer conjugates as compared to the absorbance of the nanomaterials 
alone dispersed in solution.  The peak positions are shifted by 29, 28, and 21 nm, 
respectively.  These shifts in the plasmon resonance are likely due to the difference in the 
refractive index (RI) between water and a protein crystal.
26
   
We analyzed these peak shifts quantitatively for the gold nanorod (AunRod) composite 
protein crystals to confirm that the shifts were due solely to refractive index changes and 
not to cooperative interactions between metal nanoparticles. The shaped gold 
nanoparticles have interesting absorbance spectrum properties; the width and length of 
the rod have different peak absorbance positions resulting in two plasmon resonances in 
the absorbance spectrum. Figure 5.8D shows the absorbance of a gold nanorod sample; 
the smaller peak around 520 nm is the transverse peak and the larger peak centered 
around 750 nm is the longitudinal peak.  The shape, relative intensities and position of 
the transverse peak were conserved in the AunRod composite crystal absorbance 
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spectrum; however the longitudinal peak position shows a shift of 33 nm. From the 
literature, the expected shift due to refractive index changes is 170 nm per RI unit.
27
  We 
used a RI for water of 1.33 for the initial solution conditions; for the lysozyme crystal we 
took a refractive index of 1.56 ± 0.01.
28
 This data predicts a peak shift between 32 and 38 
nm, in good agreement with the measured value.  This suggests that the nanorods are 
non-interacting and non-aggregating in the crystal, and thus separated by at least twice 
their diameter.  
 
Figure 5.8  Optical absorbance spectrums 
 
Optical absorbance spectrum of solutions (black lines) and composite crystals dried 
out of solution (blue lines) for gold nanoparticles spherical with diameters of (A) 
10 nm, (B) 15 nm, and (C) 20 nm, and (D) gold nanorods with an aspect ratio of 
2.6 ±0.3.  
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Quantum dot composite crystals have a slight blue shift in absorbance and an enhanced 
relative fluorescence over their materials dispersed in solution.  Figure 5.9, shows an 
image of a UV illuminated solution containing quantum dots and quantum dot composite 
crystals accumulated on the wall of a cuvette.  Both materials are fluorescent at a similar 
wavelength.  The optical absorbance data in Figure 5.9B shows the solid quantum dot 
composite crystal sample has several additional peaks and a blue-shifted exciton 
absorption.  Like the resonances of the metallic particles, the quantum dot absorption 
peak is somewhat sensitive to the local refractive index which is likely the cause of the 
modest blue shift in exciton absorption. The peaks to the red of the primary excitonic 
feature are more unusual, and could be attributed to absorbances from the crosslinked 
crystals or charge transfers between quantum dots.
29
   
Unlike the optical absorption which is different in the crystal as opposed to the solution, 
the fluorescence remains identical in its primary emission wavelength (Figure 5.9C).  
What is different, however, is the relative emission intensity of the solid protein crystals.  
This value was found by normalizing the emission collected from a set of crystals or a 
solution to the maximum optical absorption of the same sample; this data reveals that the 
protein-quantum dot crystals have a 15-fold increase in their effective quantum yield.  
This is a striking and potentially important finding as maximizing the quantum yields 
from these materials has been of major interest for decades.
30
 
Two factors need to be controlled for future experiments in order to confirm this finding.  
First, the samples used have an irregular distribution of crystals on the wall of the cuvette 
and provide variability in the sampling area. This could lead to the absorbance and 
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fluorescence data being collected on different areas containing different population of 
crystals, which would mean the normalization for the absorbance intensity would be 
inaccurate.  Another contribution to the difference could have arisen from reflection off 
of the crystal surfaces.  In a fluorescence collection this could have favored emission at 
ninety degree collection angles. Further work on the linear and non-linear optical 
properties of these composite materials should be pursued, preferably on a single crystal.  
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Figure 5.9  Optical properties of crystals containing quantum dots. 
 
5.2.5. Magnetic nanoparticles in protein crystals have novel behavior 
Figure 5.10 A and B shows the accumulation of composite crystals containing magnetic 
nanoparticles at the site of a small hand held magnet.  While this is similar to that seen 
for the isolated particles, more quantitative studies of the magnetization of the composites 
Optical properties of composite crystals containing quantum dots. (A) Both the 
solution and quantum dot composite crystals are fluorescent under UV light. (B) 
The optical absorbance spectrum of solutions (black lines) and composite crystals 
(blue lines) dried out of solution. (C) Emission profiles for solution of disperse 
quantum dots and composite crystals grown on the wall of the cuvette.  (D) 
Relative emission intensity (Emission/Absorbance) for the composite crystal 
sample is high.  
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detect substantial differences between the individual magnetic nanoparticle behavior and 
the behavior in the protein crystal composite.  Figure 5.10 C and D show how the 
magnetization of a collection of composite protein crystals varies as a function of the 
applied magnetic field.  Unlike isolated nanoparticles, or nanoparticles loaded into 
polymers, these samples do not show any coercivity at low temperatures.  They are 
effectively non-magnetic.  Based on the lack of coercivity for the crystals the particles 
must be non-interacting, separated by more than twice their diameter. Our current 
hypothesis for why they showed magnetic response in solution and not on analysis is that 
for this analysis the protein crystals had to be fully dried after cross-linking; the lack of 
any internal solvent is thus one difference between these samples.  There is some 
suggestion that the magnetic properties of nanoparticles constrained in a porous matrix 
require the coordination of their magnetic spin with associated solvent molecules.
31,32
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Figure 5.10 Magnetic properties of composite 
crystals
 
5.3. CONCLUSION 
Nanoparticles coated with PEG molecules in a mushroom conformation are incorporated 
into protein crystal lattices. This observation is quite general and a wide range of 
nanoparticle diameters, shapes and compositions could be concentrated in the growing 
Magnetic properties of composite crystals containing nanomagnetite. (A&B) The 
application of a hand held magnet to the solution of composite crystals results in 
the accumulation of the materials at the site of the magnet.  Magnetic response (C) 
at high temperature and (D) low temperature show superparamagnetic behavior for 
nanoscale magnetite alone (blue lines) and no magnetic susceptibility for the 
composite crystals (red lines).  
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lattice of lysozyme.  The composite crystals retain the properties of the incorporated 
nanomaterials; for quantum dots there may be some cooperative properties that enhance 
optical emission.  In the case of iron oxide particles the low temperature magnetization 
properties are quite different than bulk nanoparticle powders.  
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Chapter 6 
THE ARRANGEMENT OF NANOPARTICLES 
WITHIN PROTEIN CRYSTALS 
6.1. INTRODUCTION 
At the end of Professor Alivisatos’ 1996 article in Science he stated, “New physics and 
chemistry are sure to be discovered as [controlled arrangements of nanostructures in] 
complex assemblies are investigated.”1 Indeed the arrangement of inorganic 
nanomaterials of all types has led to the discovery of interesting properties, above and 
beyond the size dependent phenomena that have been intriguing investigators for years.  
*Work performed within this chapter is the collaborative efforts of me and members of 
the Colvin lab, Hafner lab and Shamoo lab. Courtney Payne (Hafner lab) provided all of 
the PEGylated shaped gold nanoparticles, Dr. Carolina Avendano (Colvin lab) ran 
powder XRD, acted as a liaison between myself and the Advance Photon Source for 
synchetron powder XRD collection, Zuzanna Lewicka (Colvin lab) sputter coated and 
acquired all SEM images, Lindsey Anderson (Hafner lab) ran all single crystal 
polarization dependent spectroscopy experiments, Kasia Walkiewicz (Shamoo lab) 
provided training for crystallization techniques, and ran and processed single crystal 
diffraction data. In addition, I had help from an intern: Michael Lillierose (composite 
crystal preparation). 
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Architectures of nanoparticles generate unique cooperative and ensemble dependent 
properties.  For clarity, cooperative properties will be defined as those driven by 
interactions between two adjacent nanomaterials, while ensemble properties are those 
based on interactions between all nanomaterials within three dimensional organized 
arrays.   
The cooperative effects have been studied extensively for two dimensional arrangements 
of metallic, semiconducting and magnetic nanomaterials. The distance between particles 
plays a major role in the demonstration of cooperative effects. Generally, particles closer 
than two times their diameter are coupled altering expected characteristics or producing 
new properties. Two interacting spherical metallic nanoparticles have predictable shifts in 
the spectral absorbance peaks based on the particles’ diameters, interparticle distance and 
the polarization of the incident light.
3
  Anisotropic metal nanomaterials’ cooperative 
properties are additionally effected by the symmetry and orientation of the particles 
relative to one another.
4
  There is a strong distance dependence for the coupling effects of 
quantum dots, where closer particles have decreased photoluminescence intensities due to 
increased decay rates and charge transfers.
5-7
 Like quantum dots, close interparticle 
distances for magnetic nanomaterials lead to loss of their size dependent properties; 
however, being too separated will lead to the loss of the materials ability to respond to a 
magnetic field.
8-10
  From these studies in two dimensional systems an understanding of 
the parameters for interactions between nanoparticles necessary to produce measurable 
changes in spectral absorbance, emission and magnetic response has been advanced.  
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Unfortunately, ensemble properties are not as well understood and can differ from the 
cooperative properties seen for the same materials.  Metallic nanoparticle ensembles 
show greater spectral shifts, but surprisingly there are also decreased bandwidth for 3D 
arrangements, over the 2D structures.
11,12
  The photoluminescence intensity for 
superstructures of quantum dots was shown to increase with the addition of  layers in a 
3D arrangement.
13
 However, most of the reported ensemble properties are for multiple 
layers of self-assembled hexagonal-close-packed lattices of nanoparticles, with little to no 
long range control over the distance between particles or variations in their arrangement. 
By utilizing biomolecules for the spatial organization of nanoparticles, the distance and 
coordination of nanoparticles can be controlled in three dimensions and their properties 
explored to obtain a better understanding of the ensemble effect within disperse arrays of 
nanoparticles.    
Here we use four methods to determine the arrangement of nanoparticles within a protein 
crystal: qualitative imaging and quantitative approaches of diffraction, high magnification 
visualization and polarization dependent single crystal spectroscopy. Light and confocal 
microscopy techniques were used to assess general incorporation based on the uniformity 
and distribution of observable color or fluorescence within the crystals.  More 
quantitative approaches were aimed at determining the actual distances and spatial 
arrangement of the nanomaterials; which is exceedingly difficult given that the 
nanoparticles are tens of nanometers and the crystals are greater than 100 μm, effectively 
creating features that span size differences of four orders of magnitude.  Unfortunately, 
diffraction patterns were unable to provide conclusive evidence of the nanoparticle 
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arrangement.  However, the electron microscopy techniques (TEM and SEM) were 
effective means for the visualization of some of the nanoparticles.  TEM successfully 
resolved smaller nanoparticles, but could only be used on small areas or thin sections of 
the crystal. SEM images were able to provide more useful information and allow 
determination of the spatial arrangements because it could be used to image both large 
areas and small nanoparticles on a single surface of the crystals.  Images from both 
electron microscope techniques showed a distribution of unaggregated nanomaterials 
throughout the crystal, with regions of alignment for samples containing anisotropic 
particles. Nanorods on the surface and interior of the crystal had less than a 20 degree 
deviation from the average angle of the sample and aligned perpendicular to the c-axis of 
the lysozyme crystals.  Polarization dependent spectroscopy confirmed these results 
showing long range alignment throughout the protein crystal for anisotropic materials, 
based on a significant decrease in the optical absorbance at their longitudinal peak with 
changes in the polarization of incident light.  
6.2. RESULTS AND DISCUSSION 
6.2.1. Microscopic examination 
The arrangement of nanoparticles within any three dimensional array is of the utmost 
importance, because the regularity and interparticle distance are the major factors 
influencing the occurrence of cooperative and ensemble properties for arrays of 
nanoparticles.  Nanomaterials incorporated into protein crystals show uniform coloration 
and intensity when, assessed visually, using light or confocal microscopy.  Figure 6.1, 
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shows the {110} and the {101} faces for control crystals, gold nanoparticle composite 
crystals imaged by a light microscope and quantum dots composite crystals imaged by a 
confocal microscope.  The nanoparticle distributions in these images appear to be 
uniform from one edge of the crystals to the other. For the incorporation of most 
polymer-nanoparticle conjugates such homogeneous colors were typical. However, a 
more controlled distribution of materials could be obtained by altering the nanoparticle – 
protein associations or the crystallization conditions.  
 
Figure 6.1 Microscopic images of lysozyme crystals 
 
 Light microscope (A,B,D,E) and confocal microscope (C,F) images of lysozyme 
crystals {101} planes (A-C) and {110} (D-E) for control crystals formed without 
nanoparticles (A,D), AuNP_5KPEG (B,E), and quantum dot (C,F) composite 
crystals. 
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More complicated macroscopic architectures could be formed including what we term 
selective domain crystals, (Figure 6.2A) or core / shell structures (Figure 6.2B). Figure 
6.2C, from ref [2], shows the sectors of a lysozyme crystal; there are 8 {101} and 4 
{110}. Takeda et. al. produce similar architectures and they postulated that the 
distributions occurred due to electrostatic associations between poly(acrylic acid) coated 
onto gold nanoparticles (AuNP_PAA) and lysozyme.
2
  Similarly, short molecular weight 
PEG nanoparticle-conjugates that are not fully sterically stabilized by poly(ethylene) 
glycol can be rendered stable while still maintaining a net negative surface charge.  These 
states have mainly been seen for short molecular weight polymer coated nanoparticles, 
after being stored for > 1 month without any excess PEG in solution. Through dynamic 
equilibrium, the coating materials are depleted creating a surface charge for electrostatic 
associations with lysozyme. Takeda et al, reported that electrostatic associations are 
greater with the crystal {101} surface than the {110} surface due to differences in the 
growth kinetics between the faces.
2
 These crystals show the typical “hourglass” 
coloration pattern from the selective regions where incorporation occurs. 
Another selective incorporation formation occurs when nanoparticles are restricted only 
to the core of the protein crystal (Figure 6.2B); this geometry is fairly simple to achieve 
simply by diluting the nanoparticle concentration after crystal growth has started or 
starting with low initial concentrations of nanoparticles that deplete as the crystals grow.  
The crystals shown in Figure 6.2B were formed from a concentration gradient which was 
produced when large, high aspect ratio gold nanorods slowly settled out of solution.  The 
scheme in Figure 6.2D shows that core/shell crystal form only at the top of the vial, 
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where the nanoparticle concentration was depleted the fastest. Low initial concentrations 
of nanoparticles were also used to form crystals with a higher concentration of 
nanoparticles at the core. Because of the selective uptake of nanoparticles the 
concentration of nanoparticles in the center are greater than the edges however the 
distribution between core and shell for these samples were more diffuse.  
 
Figure 6.2. Selective domain and core/shell distribution of nanoparticles 
 
Uneven incorporations, (A) selective domain composite crystals produced for 
under coated AuNP_2KPEG nanoparticles. (B) Core /shell distributions have 
nanoparticles at the core and clear outer edges of the crystals.  (C) Preferential 
incorporation into the 8 {101} face results in an hour glass shaped red color, image 
from ref [
2
]. (D) Core / shell crystals form when the nanoparticle concentration is 
depleted out of solution, through processes such as sedimentation. 
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6.2.2.  Diffraction analysis 
While micrographs provide qualitative information about the distribution of 
nanomaterials in macroscopic crystals, they do not show the spacing or arrangement of 
the particles on a nanometer scale.  The first approach used to determine the 
crystallographic arrangement of nanoparticles was diffraction.  Powder and single crystal 
X-ray diffraction patterns were collected for four crystal samples: one control lysozyme 
without any nanoparticles, and three composite crystals formed with gold nanoparticles 
coated with 10,000 molecular weight PEG. The first two composite crystal samples were 
prepared with 10 nm spherical particles at two loading concentrations: a low 
concentration, 1 nM and a high concentration, 10 nM.  Additionally, composite crystals 
saturated with gold nanorods (AunRod) were also analyzed.  
The diffraction patterns collected on all protein crystals showed reflections consistent 
with the lysozyme crystal lattice.  For all four samples the lysozyme structure remained 
identical in terms of the symmetry point group and unit cell dimensions. The only 
observable changes with the addition of gold nanoparticles were decreases in crystal 
diffraction quality as seen in the decreased resolution limit and increased mosaicity. 
Table 1 is a comparison of the diffraction data collected for a control crystal and the high 
concentration protein crystal-nanoparticle composite.  The resolution limits for the 
control, AuNP_[low], AuNP_[high], and AunRod crystals. were 1.60, 1.60, 1.60 and 2.0 
Å and the mosaicity values were 0.55, 1.1, 2.76 and 0.8, respectively. 
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Table 6.1 Summary of single crystal diffration data collection statistics
 
 
Powder x-ray diffraction was also explored for these materials in the hopes of 
determining low angle peaks that might signify crystallographic arrangement of 
nanoparticles.  Samples for powder diffraction were first cleaned and crosslinked, then 
further purified and dried; finally they were smashed or ground to a fine powder.  
Without the additional cleaning step only peaks arising from the buffer salts used in the 
crystallization growth media were observed.  Powder diffraction data was first collected 
on a Rigaku XRD with a copper Kα source and a zero background holder.  Figure 6.3 
shows the comparison of the lysozyme control pattern and the AuNP_[high] pattern. The 
large two theta angles show the pattern for crystalline gold, which confirms the presence 
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of the nanoparticles in the samples.  At low two-theta angles there are peaks that are 
consistent with those observed for the cross linked lysozyme crystal controls; these peaks 
showed no significant shifts, as shown in table 2.
14
  However, the amount of noise and 
the interference from the small angle X-ray scattering made resolving the protein peaks 
difficult.   
 
Figure 6.3 Powder X-ray diffraction data 
 
Powder X-ray diffraction data (offset for clarity) collected for lysozyme control 
crystals (black line) and AuNP_[high] composite crystals. Lysozyme peaks are 
seen in the low two-theta angles (blue stars) and gold peaks are seen in the larger 
two-theta angles (red diamonds). 
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Table 6.2 Lattice spacing for lysozyme
 
 
To obtain better powder diffraction data at the low two theta angles, samples were sent to 
the Advanced Photon Source at Argonne National Laboratories, where the diffraction 
data was collected on a syncetron beam line for angles from 1 – 42 degrees.  The series of 
peaks, shown in Figure 6.4A, at the low two-theta were similar for all four samples and 
closely matched in position and intensity.  In the higher two-theta the incorporation of 
gold nanoparticles was again confirmed by the presence of concentration dependent gold 
peaks in the composite crystal samples.   
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Figure 6.4  High resolution-low angle powder X-ray diffraction data 
 
Based on the diffraction data, all peaks were identified as either lysozyme or gold and did 
not indicate the placement of particles within the crystal.  If there were regular patterns of 
Data shown was collected at 20eV on the BM-1 rapid access powder diffraction 
beam line.  Samples are lysozyme control crystals (black), AuNP_[low] (blue), 
AuNP_[high] (red), and AunRod (purple) composite crystals (baseline subtracted 
and offset for clarity). (A&B) Low angle 2theta data show peaks that match well to 
the lysozyme control crystals.  (B) Zoomed in on the lowest 2theta region of graph 
A, the red dotted line indicates the only peak that is absent in the control sample 
and increases with gold concentration in this region of the spectra. (C) High angle 
2theta have concentration dependent gold peaks.   
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nanoparticles within the protein lattice, then very small two-theta peaks may be present.  
A careful examination of Figure 6.4 (B) shows a low angle peak just above 1 that grows 
with nanoparticle loading volumes.  To further examine this region requires larger 
distances between the sample and detector with better resolution at low two-theta 
position. Currently, there is too much interference from the lysozyme diffraction to draw 
and conclusions regarding the nanoparticle arrangement using diffraction data. 
6.2.3. Electron microscopy 
Electron microscopes were used at high magnification to detect the presence and 
arrangement of nanoparticles within the protein crystal composites. Transmission 
electron microscopy (TEM) was used with an analytical scanning imaging device (ASID) 
to perform scanning transmission electron microscopy (STEM) imaging in high angle 
angular dark field (HAADF) to image the thick composite crystals and detect the 
nanoparticle positions.  Figure 6.5 shows the HAADF images of AuNP_[high] crystals at 
two magnifications. The nanoparticles are distributed throughout the crystal even at the 
edge.  However, determining the distribution of these nanoparticles within the crystals 
was impossible because the sample sections were relatively thick and the crystallographic 
angle for the exposed surfaces was not known.  
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Figure 6.5 HAADF images of AuNP [high] composite crystals. 
 
Scanning electron microscopy (SEM) images were obtained of the crystal surfaces and 
used to analyze the arrangement of nanoparticles at or near the surface.  Since SEM 
images are acquired for just one plane of the crystals the influence of depth, which 
plagued the analysis of TEM images was eliminated.  Figure 6.6 are SEM images 
obtained from the surface of control, AuNP_[low], AuNP_[high] and AunRod samples. 
The lysozyme control sample is smooth without any pitting.  The AuNP composite 
crystal surfaces have shadowy pits that are on the scale of the 10 nm particles and the 
AunRod crystal surface clearly shows the large gold nanorods.  The AuNP_[high] sample 
image was adjusted for contrast and brightness then analyzed using ImagePro software to 
perform radial distribution functions and determine the average distance between 
particles and their first and second closest neighbor.   
All scale bars are 200 nm. 
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Figure 6.6  SEM images of crystal surface 
 
  
SEM images of a crystal surface for the control sample (A), AuNP_[low] (B), 
AuNP_[high] (C) and AunRod (D) composite crystals.  
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This analysis revealed that the distribution of 10 nm gold nanoparticles was not entirely 
random; there was a fairly narrow average distance and some consistency in the 
interparticle arrangements. Figure 6.7 shows the adjusted AuNP_[high] SEM image from 
which a mask was generated to determine the center position for all the darkened divots 
on the surface. Next, the coordinates for the particles were used to determine the 
distances between single particles and all other particles in the image (1355).  The 
distances were used to determine the average spacing for the closest and second closest 
neighbors. The histograms shown in Figure 6.7B are the distances to first and second 
closest neighbors for 123 particles chosen at random revealing an average to 47.5 ± 1.9 
nm and 63.0 ± 3.4 nm, respectively. The low variance in distances suggests that the 
particles are regularly spaced.   
Next, the position of a central particle was used to calculate the radial distribution 
function (RDF), g(r), for the arrangement.  RDFs are used to determine how a 
distribution of particles varies based on the distance from a reference particle.  First, the 
number of particles (n) within a given area away from the central particle was calculated 
for the whole image in 10 nm incremented radial changes.  Then the number of particles 
per volume of the shell (Vradial shell) was determined where Vradial shell was approximated 
using equation 6.1; where r, was the radial distance from the particle and δr, was the 
incremented change (10 nm). 
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Equation 6.1. Volume of the radial shell 
                  
    
Then g(r) is calculated using equation 2; where N was the total number of particles and 
Vtotal was the the total image analyzed: 
 
Equation 6.2. Radial distribution function 
 ( )  
 
      
 
 
      
 
 
The RDF for the AuNP_[high] sample is shown in Figure 6.7C&D are consistent with 10 
nm particles at arranged spacings within 250 nm of the central particle.  Further away the 
distributions become more irregular.   
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Figure 6.7 SEM image and analysis for nanoparticle arrangement in 
AuNP [high] crystal 
 
  
(A) The SEM image from Figure 6 of the AuNP_[high] crystal surface was 
enhanced for contrast and brightness. (B) Average distance to first and second 
closest neighbors was found to be 47.5 ± 1.9 nm and 63.0 ± 3.4 nm, respectively. 
The radial distribution function from a single central particle for (C) 1.5 μm and 
(D) 0.5 μm area around the central particle. 
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These data allow us to better understand the optical data presented in Chapter 5.2.4. 
Interparticle distances must be less than twice the diameter of gold nanoparticles in order 
to couple plasmon resonances in adjacent gold nanoparticles.  Here their spacing was on 
the order of five times their diameter.
3
 
The evaluation of the gold nanorods based on the center to center distance and RDF are 
shown in Figure 6.8 and were calculated for the surface exposed nanoparticles in the 
SEM images in a fashion similar to that applied to the spherical nanparticles.  The center 
to center distance between nanorods was found to be 79.4 ± 8.7 nm.  The RDF for the 
rods showed a similar trend in arrangement, namely a regularity in the spacing for the 
distribution within two neighbors. However, more significant in this anlaysis was the 
degree of alignment for the exposed rods.  
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Figure 6.8  Image and analysis of arrangement of AunRod composite 
crystal 
 
 
(A) The SEM image from Figure 6 of the AunRod composite crystal. (B) Average 
distance to the closest neighboring particle, 79.4 ± 8.7 nm. The radial distribution 
function from a single central particle for (C) 1.5 μm and (D) 0.5 μm. 
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Nanorods are highly aligned on the surface and within the interior of the composite 
crystals, Figure 6.9.  Composite crystals were evaluated based on the particles that could 
be visualized both on the surface of the crystal and within the interior; crystals were 
embedded in resin and sliced in half to image deeper into the crystal. Analysis of the 
SEM images show the nanorods on the surface align within 21.4° of the average angle 
(1050 particles, even without correcting for surface defects) and within 11.2° for all 
interior rods (180 particles).  These highly aligned particles show different orientations 
on each of the faces, Figure 6.9C shows the intersection of two faces of the crystal with 
rods aligning perpendicular to the long axis of the crystal, but also orthogonal to each 
other. Images obtained over a large area of a single face showed all the rods oriented the 
same way across the face.  
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Figure 6.9 Nanorod Alignment Images and Analysis 
 
(A & C) Nanorods at the surface of as prepared protein crystals and (B &D) the 
interior of resin embedded, crystals that were sliced in half. Polarization plots were 
used to show the nanomaterials alignment throughout the crystal sample, (E) 
surface rods, (F) interior rods.   
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6.2.4. Polarization dependent optical signal from aligned nanorods 
The long range alignment of the nanorods within the composite crystal leads to a strong 
polarization dependent optical signal in the longitudinal peak spectrum. Figure 6.10 
shows the optical properties of the crystals as collected on a single crystal at two 
locations.  The arrangement of the eight {110} segments form the characteristic hourglass 
shape in image A.  From the SEM data it was determined that the gold nanorods align 
perpendicular to the long axis of the crystal, and that the faces align perpendicular to each 
other.  Therefore, along the {101} surfaces facing towards and away from the camera the 
rods would be oriented parallel with the direction of the slits, and the rods within the 
faces on the left and right sides would be pointed towards the camera.  This orientation of 
the rods would look like a sphere to the camera and incident light, which should show no 
interaction with the polarized light.  
Image A and spectrum D show that the {101} segments on the two sides of the crystal do 
not interact with polarized light and are therefore arranged with the long axis towards the 
camera. However, the loss of color and decreased spectral absorbance for the top and 
bottom areas crystal is notable.  It suggests that the long axis of the rods interacts with 
polarized light; at 0 degrees the polarized light is parallel to the slit direction while at 90 
degrees the incident light is perpendicular to the long axis of the rod.  
Protein crystals are known to interact with polarized light, and so we checked that the 
observed polarization properties were due to rod alignment and not to the native crystals 
themselves. Single crystal polarization dependent spectrum was collected for spherical 
AuNP composite crystals as well.  The decrease in absorbance at the peak position for the 
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two domains of the spherical AuNP crystals were 25% and 20%.  The non-interacting 
domain of the composite crystal had a decrease in absorbance of 29%, while the 
interacting domain decreased in absorbance by 64%.  Therefore the reflections within the 
crystal may account for up to ~30% of the polarization dependent decrease in the 
absorbance spectrum, but the interacting, aligned anisotropic materials have a more 
significant decrease in optical absorbance.  
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Figure 6.10 Polarization of AunRod Composite Crystal 
 
 
Images of a single AuRod composite crystal for two incident light polarization 
positions; (A) at 0 degrees and (B) 90 degrees. Polarization dependent absorbance 
spectra collected on the crystal in 10 degree increments at two slit positions, (C) for 
the slit represented by the blue line position and (D) the green line position.  
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6.2.5. Mechanism of arrangement 
The incorporation and arrangement of nanoparticles at regular distances within the 
protein crystal is reflective of the fact that the nanoparticles help form protein crystal 
nuclei; for lysozyme, these nuclei have been studied via both light scattering and 
diffraction.  Most studies find that they consist of four or more lysozymes with 
dimensions near 9 to 18 nm.
15,16
  In this the presence of nanoparticles, these proto-nuclei 
form in and around nanoparticle-polymer conjugates that can themselves can have 
polymer shells as thick as 30 nm.  This would suggest that incorporated nanoparticles 
could have as much as 40 to 50 nm of surface polymer and protein surrounding them, 
giving rise to a lower limit for the interparticle separations that is in good agreement with 
that found from the radial distribution function (e.g. 47 nm).  The composites grow when 
these proto-nuclei encounter other similar structures and begin to crystallize, leading to 
the formation of composite crystals. 
Alignment of the anisotropic materials is believed to be due to increased interactions with 
the protein on the higher radius of curvature ends of the nanoparticles.  For spherical 
nanoparticles the radius of curvature polymers of sufficient length are less extended, yet 
as the nanoparticle radius increases the polymer extension increases to a brush 
conformation
17
. This would prevent protein association with the long sides of the rod, and 
create proto-nuclei more at the ends of rods.  Accumulation of proteins increases the 
protein – protein associations and leads to the nucleation of crystal growth preferentially 
at the ends in a matter that decorates their tips.  These then link with other tip-decorated 
rods to form aligned arrays.  
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6.3. CONCLUSION 
Evaluation of the arrangement of nanoparticles within composite crystals was approached 
via four methods. Visually, composite crystals show controlled distributions of 
nanoparticles throughout their structure, but no information can be obtained about the 
nanometer scale spatial arrangements.  More quantitative approaches such as diffraction 
were also of limited utility, primarily because peaks from the lysozyme crystal itself 
overwhelmed any weaker scattering patterns from aligned nanoparticles. Electron 
microscopy resolved the particles on the nanometer scale, but for transmission electron 
microscopy the inability to look along specific axes made it challenging to assess the 
arrangement of nanoparticles.  SEM proved to be most useful for detecting nanoparticles 
in a single plane and showed some regularity in spacing and a high degree of alignment 
for anisotropic materials.  Long range alignments of anisotropic materials were confirmed 
with single crystal polarization dependent spectroscopy.  Through surface design it was 
possible to produce concentrated composites of a variety of nanoparticles with some 
degree of control over interparticle spacing as well as rod alignment. 
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CONCLUSION 
The work documented within this thesis aimed to accomplish three main goals: 1) 
understand and control protein association through surface engineering of nanoparticles, 
2) use the protein – nanoparticle association for protein crystal nucleation and 3) 
manipulate nanoparticles into three dimentional assemblies using mesoscopic 
biotemplates.  
First, protein-nanoparticle associations were found to be dependent on the polymer 
surface grafting density for poly(ethylene glycol) (PEG) coated 10 nm gold nanoparticles.  
Two analytical methods: analytical ultracentrifugation (AUC) and total organic carbon 
analysis (TOC), were developed to quantitatively measure the polymer grafting density 
on small volumes of polymer – nanoparticle conjugates in solution. These methods were 
validated, evaluated for sensitivity and used to characterize grafting density trends based 
on molecular weight and nanoparticle diameter. The two main parameters that can be 
used to lower grafting density to allow for nanoparticle – protein associations are 
decreased polymer concentrations or increased molecular weights.  Nanoparticles with 
incomplete polymer coverages have lower grafting densities, but are not stable in ionic 
solutions, such as biological media or buffers. Increasing the molecular weight of the 
PEG coating on the nanoparticles allow for lower surface grafting densities while 
maintaining the stability in solution.  Therefore, large molecular weight coated 
nanoparticles are able to remain dispersed and isolated in solutions and exhibit protein 
associations. 
 200 
 
Sterically stabilized large molecular weight polymer coated nanoparticles associate with 
lysozyme and act as heterogeneous crystal nucleants: increasing crystal counts, 
decreasing sizes and times to nucleation and increasing the chance of obtaining 
crystallization hits using high throughput sparse matrix screening strategies.  In contrast, 
uncoated citrate stabilized gold nanoparticles are unable to remain disperse in the high 
ionic strength crystallization buffers.  These particles fall out of solution and have little to 
no impact on  protein crystallization.  Similarly, short molecular weight polymer-coated 
nanoparticles, which do not exhibit protein association, have little to no influence on 
protein crystallization.  Nanoparticle nucleants in the protein stock solution are easily 
incorporated into high throughput crystallization strategies where they increase the 
crystal forming conditions while also decreasing the precipitate forming conditions for a 
diverse set of six proteins: ferritin, human serum albumin, lipase b, xylanase, glucose 
isomerase and lysozyme.  
Finally, nanoparticles coated with large molecular weight PEG were incorporated into the 
protein crystal lattice forming mesoscopic, three dimensional, biotemplated, architectures 
of well-formed nanoparticles.  Surface modification of nanoparticles, such as coating 
with PEG, can be used to form composite crystals with nanomaterials of a wide range of 
sizes (7.5 – 42 nm), shapes (cube, bipyramid, rod and high aspect ratio rods) and core 
compositions (iron oxide, cerium oxide and quantum dots).  Based on interparticle 
distances, nanomaterials exhibit optical, fluorescent and magnetic properties that can 
differ from the size dependent properties of the same materials dispersed in solution.  For 
gold nanoparticle composite crystals it was determined that the distance between particles 
must be greater than twice their diameter and therefore, no significant spectral shifts were 
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observed (over those attributed to the change in refractive index). Increased quantum 
yields for quantum dot composite crystals are an indication that the incorporated 
nanomaterials were separated more than twice their diameter.  Additionally, the magnetic 
response of iron oxide nanoparticles changed after  incorporation as indicated by the 
inability of constrained, isolated nanoparticles to coordinate their spins which is 
necessary to  exhibit a magnetic response.  While these properties consistently point to a 
large separation of nanomaterials, possibly the most interesting results come from the 
long range ordering of anisotropic nanorods.  Analysis of nanorods on the faces and 
interior planes of crystals where they incorporated, showed less than 20 degree deviation 
from the average alignment angle.  Polarization dependent optical properties confirmed 
the high degree of alignment was consistent throughout the crystal and produced a 
measurable decrease in the optical absorbance at the longitudinal absorbance peak.  
